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ABSTRACT 
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David E. Marra, MS 
 
Marquette University, 2019 
 
 
  
Mild traumatic brain injuries (MTBIs) result in a constellation of non-specific 
physical, cognitive, and psychological symptoms. There is significant variability in 
neurocognitive recovery after MTBI, ranging from a few days to a few months, and 
others who fail to make complete recovery. A broad literature has attempted to elucidate 
what individual differences explain this variability. The present study sought to build 
upon previous meta-analyses, which systematically aggregated and examine relevant 
literature, by including a more heterogenous population and utilizing contemporary meta-
analytic techniques. Three online databases (PsychINFO, PubMed, MedLine) were 
searched for pertinent studies. Separate random-effects Analogue-to-ANOVA were 
utilized to examine the overall neurocognitive effects of MTBI across time points, 
stratified by age, psychological comorbidity, populations of interest (athletes, general 
medical referrals, Veterans, litigants), and whether performance validity tests (PVT) were 
utilized. Subsequent analyses utilized meta-regressive techniques to simultaneously 
examine the variables of interest. After article review, 109 studies were retained for 
analysis (NMTBI = 5919, NControl = 8318). Analogue-to-ANOVA analyses revealed a 
medium-large overall neurocognitive effect size in the first 24 hours post-injury (d = .64) 
that decreased to a small effect size over the first 90 days (d = .24). Driven by a higher 
number of Veteran and litigant samples, the effect size increased in the post-acute period 
(> 90 days; d = .39). Veteran samples were observed to have significantly larger effect 
sizes than other populations considered. Meta-regressive analyses found that, across 
heterogenous populations, time since injury (TSI) was predictive of overall cognitive 
function only prior to 90 days post-injury, but not in the post-acute period. Psychological 
functioning was the most important predictor of cognitive functioning after MTBI (β = 
.47), over and above TSI, population, demographic variables, injury parameters, age, or 
PVT. This study is consistent with the growing research suggesting that psychological 
functioning largely explains MTBI recovery and suggests that assessment of emotional 
well-being and psychological functioning should be part of routine clinical care for the 
management of MTBI. 
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Neuropsychological Sequela of Mild Traumatic Brain Injury: 
A Contemporary Meta-Analytic Review 
 
A traumatic brain injury (TBI), generally, occurs when brain functioning is 
disrupted or brain pathology arises due to an external force (Menon, Schwab, Wright, & 
Maas, 2010). Researchers and clinicians typically classify TBI by severity (e.g., mild, 
moderate, severe). Seventy to ninety percent of all medically treated TBIs are mild in 
nature (Cassidy et al., 2004). Mild traumatic brain injury (MTBI), or concussion, is 
extremely common, affecting as many as 42 million people annually and 12 percent of all 
individuals during their lifetime (Cassidy et al., 2004).   
 MTBI may result in a constellation of non-specific physical, cognitive, and 
psychological symptoms (McCrea, 2008). For most individuals, these symptoms resolve 
in fewer than three months (Carroll et al., 2004). However, for reasons not completely 
understood, a small, yet significant number of individuals continue to experience 
distressing symptoms years after an injury. Furthermore, the relationship between these 
chronic, self-reported symptoms and neuropsychological outcomes are poorly 
understood. The cognitive sequela that arise post-MTBI appear to differ across time for 
different patient populations. Thus, it is critically important to consider how biological, 
psychological, and/or social factors impact recovery. 
Defining MTBI 
 Until recently, there was no universally accepted definition of MTBI. The lack of 
a sound operational definition for diagnosis has resulted in considerable discrepancies in 
the MTBI literature (Cassidy et al., 2004). In addition, standard imaging techniques, such 
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as MRIs and CT scans, do not detect “uncomplicated” MTBIs (i.e., a MTBI that does not 
result in cranial fracture or intracranial bleed) and therefore have low diagnostic utility. 
More sophisticated imaging techniques, such as Diffusion Tensor Imaging (DTI) can 
detect group-level differences between concussed and non-concussed individuals (e.g., 
Ivanov et al., 2017); however, these imaging techniques are not yet sensitive enough for 
routine clinical application (Asken, DeKosky, Clugston, Jaffee, & Bauer, 2017 Jaffee, & 
Bauer, 2017). At present, the same holds true for other biomarkers, such as cerebral 
spinal fluid and bloodwork (Lewis et al., 2017; c.f., Nitta et al., 2019).  
The diagnosis of MTBI is made on the basis that a transient disruption of 
cognitive functioning that occurred due to a direct or indirect impact to the head. The 
American Congress of Rehabilitation Medicine (ACRM) and the World Health 
Organization (WHO) Task Force (Carroll et al., 2004) provide two well-accepted MTBI 
definitions. Both the ACRM and WHO Task Force define MTBI as an acute disruption of 
brain functioning due to trauma that manifests as one or more of the following (1) loss of 
consciousness (LOC) less than 30 minutes, (2) altered mental state (e.g., dazed, 
disoriented, or confused), (3) pre- or post-traumatic amnesia less than 24 hours, and (4) a 
Glasgow Coma Scale score between 13-15 after 30 minutes (see Table 1 for complete 
diagnostic criteria). Uniquely, relative to earlier diagnostic criteria, these classification 
systems do not require the presence of LOC. The main difference between the two 
classification systems, the ACRM allows for any alteration of mental state (e.g., feeling 
dazed) at the time of the accident, whereas the WHO Task Force definition specifies 
“confusion and disorientation.” While both definitions exclude patients with more severe 
injuries, critics emphasize that TBI severity should be conceptualized as a continuum 
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(Roozenbeek, Maas, & Menon, 2013). Nonetheless, these definitions operationalize 
MTBI, which certainly facilitates more reliable clinical judgement and improves 
research.   
Table 1.  
Definitions of Mild Traumatic Brain Injury and Concussion from Different Agencies  
ACRM (1993)  A patient with mild traumatic brain injury is a person who has had 
a traumatically induced physiological disruption of brain function, 
as manifested by at least one of the following:  
1. Any period of loss of consciousness;  
2. Any loss of memory for events immediately before or after 
the accident;  
3. Any alteration in mental state at the time of the accident 
(e.g., feeling dazed, disoriented or confused); and 
4. Focal deficits that may or may not be transient; but where 
the severity of the injury does not exceed the following:  
• Loss of consciousness for approximately thirty minutes 
or less;  
• After 30 minutes an initial GCS of 13-15 
• Past-traumatic amnesia not greater than 24 hours 
 
  
 
WHO Task 
Force (2004) 
 MTBI is an acute brain injury resulting from mechanical energy to 
the head from external physical forces. Operational criteria for 
clinical identification include: (i) 1 or more of the following: 
confusion or disorientation, loss of consciousness for 30 minutes or 
less, post-traumatic amnesia for less than 24 hours, and/or other 
transient neurological abnormalities such as focal signs, seizure, 
and intracranial lesion not requiring surgery; (ii) GCS score of 13-
15 after 30 minutes post-injury or later upon presentation for 
healthcare. These manifestations of MTBI must not be due to 
drugs, alcohol, medications, caused by other injuries or treatment 
for other injuries (e.g., systemic injuries, facial injuries or 
intubation), caused by other problems (e.g., physiological trauma, 
language barrier or coexisting medical conditions) or caused by 
penetrating craniocerebral injury  
 
  
 
International 
Conference of 
Concussion in 
Sport (2013)  
 
 
 Concussion is a brain injury and is defined as a complex 
pathophysiological process affecting the brain, induced by 
biomechanical forces. Several common features that incorporate 
clinical, pathologic, and biomechanical injury constructs that may 
be utilized in defining the nature of a concussive head injury 
include:  
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International 
Conference of 
Concussion in 
Sport (2013) 
Continued  
1. Concussion may be caused by a direct blow to the head, 
face, neck, or elsewhere on the body with an “impulsive” 
force transmitted to the head. 
2. Concussion typically results in the rapid onset of short-
lived impairment of neurological function that resolves 
spontaneously. However, in some cases, symptoms and 
signs may evolve over a number of minutes to hours 
3. Concussion may result in neuropathologic changes, but the 
acute clinical symptoms largely reflect a functional 
disturbance rather than a structural injury, and as such, no 
abnormality is seen on standard structural neuroimaging 
studies.  
4. Concussion results in a graded set of clinical symptoms that 
may or may not involve loss of consciousness. Resolution 
of the clinical and cognitive symptoms typically follows a 
sequential course. However, it is important to note that in 
some cases, symptoms may be prolonged.  
 
Note. ACRM = American College of Rehabilitation Medicine; WHO = World Health 
Organization; GCS = Glascow Coma Scale  
 
 Although the terms MTBI and concussion are often used interchangeably, some 
argue that sports-related concussion (SRC) is not synonymous with MTBI, but rather 
reflects a subset of mild head traumas (McCrory et al., 2013). In a Consensus Paper from 
the 4th International Conference on Concussion of Sport, concussion was defined as, “a 
complex pathophysiological process affecting the brain, induced by biomechanical 
forces” (McCory et al., 2013, pp. 555). The paper also clarifies that a concussion may be 
the result of a blow or forces transmitted to head that results in acute neurologic 
dysfunction (LOC may or may not occur). In principle, there is significant overlap 
between how concussion and MTBI are defined (Table 1); they are considered 
synonymous and analyzed together in the present study.  
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Prevalence and Significance 
 The failure to develop an agreed upon diagnostic criterion for MTBI until early 
2000 made determining the “true” prevalence rate challenging. The Center for Disease 
Control examined Emergency Department records across the United States from 2002-
2006 and estimated that 1.7 million individuals are medically treated or fatally injured 
due to TBI each year (Faul, Xu, Marlena, & Coronado, 2010). In a later report to 
Congress (Frieden, Houry, & Baldwin, 2015), it was acknowledged that the previous 
estimate of 1.7 million individuals was likely low as it did not account for individuals 
who were treated in non-hospital settings, individuals who did not receive treatment, or 
Veterans who were treated at Veteran Affairs (VA) medical centers. One meta-analysis 
attempted to quantify MTBI prevalence rates by examining the prevalence rate from all 
published studies (Cassidy et al., 2004). The authors found pervasive heterogeneity in 
methodology across studies. For example, MTBI was variably defined, if at all, by 
authors. Due to the extent of the methodological variability between studies, the authors 
expressed hesitation in providing a single incidence rate. Nonetheless, based on the 
available data, Cassidy and colleagues estimated the incidence rate to be between 100 to 
300 per 100,000 adults. Much like the CDC, the authors acknowledged that this estimate 
is likely an underestimate as a majority of MTBIs are not medically treated. It was 
estimated that the likely incidence rate approaches 600 per 100,000 adults.  
 Athletes are also susceptible to TBI and the CDC estimated that 300,000 athletes 
in the United States sustain a concussion annually (Thunnan, Branche, & Sniezek, 1998), 
or 1.64 per 100 athlete-seasons across all sports (Powell & Barber-Foss, 1999). However, 
this may be a gross underestimate as almost half of all SRC go unreported (McCrea, 
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Hammeke, Olsen, Leo, & Guskiewicz, 2004). This is especially problematic as resuming 
physical activities, especially participating in contact sports, prior to symptom resolution, 
may increase risk of sustaining another brain injury (Guskiewicz et al., 2003).   
Military personnel are also particularly vulnerable to TBIs. In fact, MTBI are so 
pervasive for active duty members it is considered the hallmark injury of recent military 
conflicts. As the mortality of soldiers have decreased over time, the prevalence of TBIs in 
this population has increased. From October 1, 2001, the start of Operation Enduring 
Freedom (OEF), to the end of 2011, 235,046 service members (4.2%) were diagnosed 
with a TBI (The CDC, NIH, DoD, and VA Leadership Panel, 2013). In 2011, alone, 
33,149 military personnel were diagnosed with a TBI. During the same 10-year period, 
7.7% of all services sought at VAs were from OEF and Operation Iraqi Freedom (OIF) 
personnel for TBI-related conditions. Similar to other MTBI estimates, these numbers 
may underestimate the true number of TBIs as many MTBIs are likely not recognized or 
reported in combat theater.  
Traumatic brain injury clearly represents a major public health issue. The 
economic cost of TBI is disproportionately larger than other injuries (Ma, Chan, & 
Carruthers, 2014; Max, MacKenzie, & Rice, 1991), with the estimated cost of treatment 
approaching $13.1 billion per year and an additional $64 billion are estimated to be lost 
due to indirect costs (e.g., inability to work, disability) (Rutland-Brown, Langlois, 
Thomas, & Xi, 2006). Furthermore, 3.32 million individuals (1.1% of total population) 
are living with long-term disability due to TBI (Zaloshnja, Miller, Langlois, & Selassie, 
2008 & Selassie, 2008). Even though more than 70% of TBIs are considered “mild” in 
severity (CDC, 2010; Cassidy et al., 2004), in some individuals, these injuries can still 
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result in permanent or long-term problems that negatively impact one’s ability to function 
(e.g., see Alves, Macciocchi, & Barth, 1993; Englander, Hall, Stimpson, & Chaffin, 
1992).  
Epidemiology and Mechanism of injury 
 Previously, motor vehicle accidents (MVAs) were the primary mechanism for 
TBIs (Cassidy et al., 2004). However, as driving policies and vehicles are becoming 
safer, the overall number of MVAs are decreasing, thus leading to a reduction in MVA-
related TBIs (Roozenbeek et al., 2013). Simultaneously, as the population grows older 
and life expectancy increases, the number of TBIs related to falls are increasing. In fact, 
an estimated 35.2% of all emergency department visits, hospitalizations, and deaths are 
fall-related (vs. 17.3% for MVAs; CDC, 2010). Older adults over the age of 75 now have 
the second highest incidence rate of TBIs, second only to younger adults, aged 15-19 
(Faul et al., 2010). Altogether, the median age of TBIs is now shifting to an older age 
(Roozenbeek et al., 2013).  
After a physical trauma, neurologic dysfunction may arise from either contact 
(blunt trauma) or inertial forces (acceleration/deceleration). The primary biophysical 
mechanisms of an MTBI arises from inertial forces (acceleration/deceleration) that is 
transferred to the brain (Meaney & Smith, 2011). Early efforts to understand the 
relationship between these forces and brain dysfunction focused on linear acceleration 
and deceleration (Meaney & Smith, 2011). Animal models showed a positive correlation 
with the initial increase of pressure in the brain and acceleration forces, which predicted 
neurologic dysfunction. However, understanding of the mechanisms of a TBI has shifted 
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to understand that the rotational forces exerted on the brain may be the predominant 
mechanism of injury (Gennarelli et al., 1982; Unterharnscheidt & Higgins, 1969). During 
rotational acceleration/deceleration, neuronal axons can tear or shear away from the cell 
body (Smith, Meaney, & Shull, 2003). The axonal tearing and shearing results in diffuse 
axonal injury (DAI), and DAI severity is associated with poorer neurological outcomes. 
In fact, if the head and neck are immobilized such that rotational forces cannot be 
applied, it is more difficult to produce unconsciousness from a physical trauma (Meaney 
& Smith, 2011).  
Symptom Recovery  
Unlike moderate and severe TBI, the non-specific constellation of cognitive, 
physical, and emotional symptoms the arise post-MTBI are not reliably predicted by 
injury parameters (e.g., loss of consciousness, post-traumatic amnesia) (McCrea, 2008). 
Clinicians and researchers track recovery post-MTBI through self-report of post-
concussive symptoms (PCS). Common self-reported PCS include, but are not limited to, 
headaches, dizziness, cognitive slowing, difficulty concentrating, light and noise 
sensitivity, fatigue, drowsiness, and memory difficulties. Important to recognize, many 
MTBI symptoms are non-specific and may be difficult to distinguish from common 
experiences and/or symptoms associated with other mental health conditions (e.g., Post-
Traumatic Stress Disorder) (American Psychiatric Association, 2013). For instance, as 
many as 75.7% of healthy volunteers reported experiencing PCS in the past two-weeks 
(e.g., headaches) despite the absence of a head injury (Iverson & Lange, 2003). 
Furthermore, there is evidence that certain populations, such as athletes, tend to 
underreport symptomology (McCrea, 2008), whereas other populations, such as 
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individuals involved in litigation, tend to over report symptomology (Feinstein, 
Ouchterlony, Somerville, & Jardine, 2001). Thus, there is need for more objective 
measures with high sensitivity and specificity to MTBI symptoms, which is crucial for 
accurate diagnosis and to monitor symptom recovery of MTBI. 
Given their relative objectivity and sensitivity to MTBI, neuropsychological 
measures are regularly utilized during a clinical evaluation to diagnose and monitor 
symptom recovery post-MTBI (McCrea, 2008). For example, in longitudinal study 
following 1,631 NCAA athletes, McCrea and colleagues found that a group of concussed 
athletes were reportedly asymptomatic based on self-report after two days, yet, continued 
to show impairment on balance and neuropsychological testing seven days post-injury 
(McCrea et al., 2005). Thus, the authors advocated that neuropsychological assessment is 
vital in detecting the subtle, residual effects of sustaining an MTBI, even in the absence 
of reported symptoms. In fact, a meta-analysis found that, in non-litigant samples, 
neurocognitive measures were sensitive to detecting the acute cognitive effects of a 
MTBI in nearly all cognitive domains (Belanger, Curtiss, Demery, Lebowitz, & 
Vanderploeg, 2005). 
Possible Modifiers of Cognitive Recovery after MTBI 
There is considerable variability regarding the cognitive effects of sustaining an 
MTBI. For example, some researchers have documented a small overall effect size (d = 
.11) at 1-month post-MTBI (Ponsford, Willmott, et al., 2000), whereas others have 
reported a moderate-large effect size (d = .64) for a similarly aged sample over the same 
time period (Voller et al., 1999). Likewise, some studies, particularly those investigating 
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athletes, show a non-significant effect size after approximately seven days (McCrea et al., 
2003), whereas other studies document that that the neurocognitive effects do not resolve 
until three or more months (e.g., Kwok, Lee, Leung, & Poon, 2008). The discrepant 
findings between studies (i.e., between-study heterogeneity) may be due to one of any 
number of factors that appear to contribute to the individual differences seen in cognitive 
recovery. A review of primary potential effect modifiers is outlined below. 
 Population. The course of neuropsychological recovery post-MTBI drastically 
differs depending on the “population” (i.e., athlete, Veteran, general-medical referral, 
litigant) investigated. Numerous studies have demonstrated that cognitive effects of 
MTBI in athletes are largely resolved in about one week (Belanger & Vanderploeg, 2005; 
Macciocchi, Barth, Alves, Rimel, & Jane, 1996; McCrea et al., 2003; McCrea, Kelly, 
Randolph, Cisler, & Berger, 2002). On the other hand, individuals who are prospectively 
recruited from emergency departments and medical clinics (i.e., general medical referrals, 
GMR) may take one to three months before neuropsychological symptoms resolve. For 
instance, many studies have reported significant effect size differences at least one month 
after MTBI (Dikmen, Machamer, & Temkin, 2017; McAllister et al., 2001; c.f., Gentilini 
et al., 1985).  Similarly, some studies have shown significant effect sizes three months 
after the initial injury (Belanger, Curtiss, et al., 2005; Gentilini, Nichelli, & Schoenhuber, 
1989; c.f., Ponsford, Willmont, et al., 2000). There are many likely reasons for the 
discrepancy in cognitive recovery between athletes and the general population that 
sustains an MTBI. First, athletes tend to be younger and healthier (i.e., high school and 
college) and have high motivation to return to play (McCrea, 2008). Furthermore, the 
mechanism of injury may differ for athletes and the general population. For instance, the 
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most common reason for an MTBI to be medically treated is due to a fall or MVA (Faul 
et al., 2010). The acceleration/deceleration forces associated with these events may be 
inherently different from SRC.  
 As previously noted, MTBI is a significant concern in military populations. 
Despite MTBI being the “hallmark” injury of OEF/OIF, there are unique challenges 
associated with studying MTBI in this population. Traumatic brain injury is often 
overlooked in favor of treating and triaging more obvious physical injuries such as 
wounds or traumatic amputations (Belanger, Scott, Scholten, Curtiss, & Vanderploeg, 
2005) and details related to injury parameters or post-injury recovery are infrequently 
documented (Belanger, Uomoto, & Vanderploeg, 2009). Alteration of consciousness may 
go unnoticed in theater, or may be confused with the emotional reaction or adrenaline 
rush likely to accompany traumatic military experiences (Belanger et al., 2009). Finally, 
from a pragmatic standpoint, neuropsychological evaluations are unlikely to be 
conducted in combat theater (Dolan et al., 2012). Nevertheless, one study investigating 
the acute effects of an MTBI found that Veterans with MTBI who were assessed in the 
first 24 hours performed significantly worse (large effect size) compared to a normative 
sample of non-concussed Veterans on a brief cognitive screener (McCrea et al., 2014). It 
is unclear when residual cognitive symptoms resolved because follow-up testing was not 
conducted in the study. Thus, it is unclear if these acute cognitive symptoms resolve in a 
few days, like athletes, or over the course of several months, similar to non-athletic 
civilians.   
Most of the research investigating how active service members and Veterans 
function post-injury have been conducted months and years after TBI. However, 
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ascertaining the neurocognitive effects of MTBI in this population is difficult because of 
several factors. Some research suggests, there is little-to-no long-term cognitive effects in 
Veterans post-deployment who suffer an MTBI when other comorbidities are absent 
(Combs et al., 2015; Nelson et al., 2012; Vasterling et al., 2012; Verfaellie, Lafleche, 
Spiro, & Bousquet, 2014). However, there is compelling evidence to suggest a potential 
negative neurocognitive effect of comorbid mental health conditions and MTBI. For 
example, Veterans with co-morbid mental-health disorders performed significantly worse 
on neurocognitive assessments compared to Veteran controls (Nelson et al., 2012) or 
Veterans who sustained an MTBI with no mental health comorbidities (Combs et al., 
2015; Verfaellie et al., 2014). Salient secondary gain issues in VA settings may also 
complicate cognitive recovery in Veterans due to the limited nature of VA healthcare 
post-deployment. Absent of a service-connected disability, Veterans in the US are 
granted only five years of VA healthcare post-deployment ("Returning Service Members 
(OEF/OIF/OND) - Health Benefits," 2014). Thus, there are clear incentives for Veterans 
to report symptomology of MTBI as early as possible (Rona et al., 2012), and there is an 
incentive to suppress performances when completing neurocognitive measures. 
Illustrating the latter, as many as 58% of a sample referred for a TBI evaluation in the VA 
system failed a performance validity test (PVT), which is a type of test designed to assess 
for sub-optimal test engagement or purposeful performance suppression (Armistead-
Jehle, 2010).  
 Importantly, insufficient effort and issues with secondary gain are not limited to 
Veterans who experience an MTBI but are also a confounding issue with civilians who 
are involved in the litigation process related to their TBI (e.g., individuals involved in a 
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motor vehicle accident and claiming disability). Members of the “litigant” population 
tend to experience greater subjective symptoms (Feinstein et al., 2001) and perform 
worse on measures of neurocognitive functioning. In fact, a meta-analysis found that the 
cognitive effects of MTBI for individuals in this group worsen over time, rather than 
resolve (Belanger, Curtiss, et al., 2005). In a large sample of individuals involved in 
litigation for MTBI, 40% failed an established PVT (Flaro, Green, & Robertson, 2007 
2007). In fact, the failure rate of the litigation group with MTBI was 23 times higher than 
a group with high motivation to perform well and twice as large as the rate observed in 
samples with more severe TBI. There is clear evidence that poor effort during the 
forensic evaluation accounts for much of the variance in cognitive testing (Green, 
Rohling, Lees-Haley, & Allen, 2001). It seems that individuals with potential secondary 
gain issues may follow a different trajectory of cognitive recovery due to factors not 
related to the injury, such as insufficient effort and symptom exaggeration. Thus, the true 
nature of their cognitive recovery is unknown.  
 Age. A significant portion of the MTBI literature investigates high school and 
college athletes. Fewer empirical studies focus on children and older adults. This 
discrepancy is notable given that children aged 0-4 years have the highest rate of ED 
visits due to TBI and adults aged 75 and older have the highest rate of hospitalizations 
and death due to TBI (Faul et al., 2010). This section will summarize research findings 
specific to these age groups to make clear that age has the potential to impact recovery.  
Studies on the acute cognitive effects of MTBI in pediatric samples are limited, in 
part because there are unique challenges associated with diagnosing MTBI in young 
children. For example, because language skills are not fully developed, it is difficult to 
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assess symptoms post-injury (Anderson, Catroppa, Morse, Haritou, & Rosenfeld, 2001). 
Nevertheless, one prospective study found that children aged 6-18 years had marginally 
lower (but not significantly lower) scores on a brief cognitive screener compared to 
controls with orthopedic injuries when evaluated acutely in an ED (Grubenhoff, 
Kirkwood, Gao, Deakyne, & Wathen, 2010). In another study, children who presented to 
an ED performed below children with orthopedic injuries on measures of psychomotor 
speed and reaction time (Brooks, Khan, Daya, Mikrogianakis, & Barlow, 2014). The 
patient groups did not perform differently on measures of memory, attention, and 
executive functioning.  
Consistent with the adult literature, there is variability and conflicting findings 
regarding long-term outcomes for children who sustain MTBI. While some researchers 
report no long-term sequela associated with pediatric MTBI (e.g., Ponsford et al., 1999), 
others express concerns regarding the possibility of long-term sequala (e.g., Anderson et 
al., 2001). In fact, a systematic review of 40 articles published between 1970 to 1995 
regarding MTBI in children and adolescents categorized 13 articles suggesting poor 
outcomes, 18 with null findings, and 9 that were uncertain regarding cognitive, academic, 
and psychosocial outcomes (Satz et al., 1997). Importantly, after reviewing only 
methodologically strong studies, the authors posited that there are few adverse or long-
term effects.  
 Consistent with the adult literature, children and adolescents’ pre-existing 
conditions and psychological comorbidities likely impact MTBI recovery. A longitudinal 
study conducted by researchers at UCLA found that, compared to controls with 
orthopedic injuries, the only predictors of cognitive impairment 1- and 12-months post-
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injury were parental education level, pre-injury behavioral issues, academic achievement, 
and pre-injury learning disorders (Babikian, McArthur, & Asarnow, 2013). Additionally, 
research has documented that children who continue to experience behavioral issues for 
extended periods of time post-MTBI are more likely to have had a previous head injury, 
learning difficulties, pre-injury emotional and behavioral problems, psychiatric problems, 
and/or additional neurological issues (Ponsford et al., 1999). In an additional study, 
children who sustained an MTBI and had pre-morbid attentional difficulties had poorer 
neuropsychological outcomes relative to children who sustained an orthopedic injury 
(Studer et al., 2014). Taken together, while it appears that children and adolescents 
demonstrate acute cognitive impairments post-MTBI that largely resolve during the 
course of a month, pre-existing factors may delay full recovery.  
Consistent with child and adolescent literature, the research regarding cognitive 
outcomes for older adults who sustain an MTBI is mixed. There are a number of studies 
that have identified adverse cognitive outcomes for older adults who sustain MTBI (e.g., 
de la Plata et al., 2008; Goleburn & Golden, 2001; Rapoport & Feinstein, 2000). 
Conversely, there are numerous studies suggesting that there are no adverse long-term 
outcomes for older adults who sustain an MTBI (e.g., Feinstein et al., 2001; Mosenthal et 
al., 2004; Rapoport et al., 2008). At closer inspection, the adverse cognitive effects may 
be a result of secondary factors, such as pain, or psychological distress. For example, 
there is evidence that older adults who sustain an MTBI perform worse than same-aged 
controls on measures of neuropsychological functioning than non-injured controls, but 
not worse than individuals who sustained orthopedic injuries (Kinsella, Olver, Ong, 
Gruen, & Hammersley, 2014) Thus, the injury characteristics (e.g., pain, medication, 
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altered sleep cycle) may account for the worse cognitive functioning, rather than the 
MTBI, itself. In addition to injury characteristics, older adults who sustain an MTBI were 
found to have higher rates of depression and anxiety symptoms relative to healthy 
controls (Goldstein, Levin, Goldman, Clark, & Altonen, 2001), which places older adults 
at a higher risk for adverse cognitive outcomes (Dotson, Resnick, & Zonderman, 2008b) . 
Psychological Comorbidities, Pre-Injury Disposition, and Post-Concussive 
Symptomatology. Even in the absence of a head injury, psychological distress and 
mental health disorders are associated with worse neurocognitive functioning (e.g., 
Dotson et al., 2008b; Gualtieri, Johnson, & Benedict, 2006; Snyder, 2013). Thus, it is 
unsurprising that the presence of a comorbid psychological disorder may prolong or 
complicate neuropsychological recovery from an MTBI (Combs et al., 2015; Nelson et 
al., 2012; Verfaellie et al., 2014). However, many additional factors, such as personality 
features and coping mechanisms, even in the absence of a comorbid mental health 
diagnosis, can extend or be the direct cause of continued symptomatology in patients who 
sustain an MTBI. For example, pre-injury somatization, anxiety sensitivity (i.e., anxiety-
related somatic symptoms), alexithymia (i.e., difficulty understanding and describing 
emotions), and depressive personality traits, have all been found to predict duration of 
post-concussive symptomology (Nelson, Tarima, et al., 2016; Wood, O'Hagan, Williams, 
McCabe, & Chadwick, 2014; Yuen, Tsai, Lin, Yang, & Huang, 2016) Interestingly, even 
in healthy, non-concussed research participants, self-reported symptoms consistent with 
PCS align with maladaptive personality constructs. Specifically, students who reported 
higher “PCS” reported more negative, depressive, anxious, dependent, sadistic, somatic, 
and borderline traits (Garden, Sullivan, & Lange, 2010).  
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The relationship between PCS symptomatology and neurocognitive functioning is 
less clear, however, as some studies found an association between neurocognitive 
dysfunction and prolonged PCS (Collie, Makdissi, Maruff, Bennell, & McCrory, 2006; 
Iverson, Gaetz, Lovell, & Collins, 2004; Sterr, Herron, Hayward, & Montaldi, 2006), and 
others have not (Chan, 2001). Stulemeijer and colleagues (2007) examined the direct link 
between pre-injury factors, PCS, and neuropsychological functioning longitudinally by 
recruiting patients from an ED and conducting evaluations 6 months post-MTBI 
(Stulemeijer, Vos, Bleijenberg, & van der Werf, 2007). Participants were dichotomized 
into groups based on cognitive complaints. Interestingly, while the high-cognitive 
complaint group did have worse pre-injury and post-injury psychological and emotional 
well-being, there were no differences in neuropsychological performance between 
groups. Thus, a clear connection between pre- and post-injury psychological functioning, 
reported PCS, and neuropsychological performance was not established. In contrast, 
another study found that worse cognitive functioning was predicted by greater cognitive 
complaints, PCS, and affective factors (depression, anxiety, and neuroticism) in 
individuals with MTBI (Clarke, Genat, & Anderson, 2012). The discrepant findings may 
be a result of the latter authors’ decision to exclude a significant portion of their sample 
(27%) due to insufficient effort. Thus, the association between poor neurocognitive 
functioning and PCS and affective symptoms in Clark and colleagues’ (2012) study may 
be an artifact of not considering whether the examinees were adequately engaged with 
testing. Thus, the link between PCS and neurocognitive functioning remains somewhat 
unclear.  
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Secondary Gain and Insufficient Effort. Secondary gain issues, insufficient 
effort, or exaggerated symptom reporting may confound interpretation of neurocognitive 
performance during standard clinical evaluations, medicolegal forensic assessments, and 
research protocols. As previously noted, Veterans may perceive an incentive to 
exaggerate symptom complaints or suppress cognitive performance to increase the 
probability of receiving service-connected disability (Hoge, Goldberg, & Castro, 2009; 
Rona et al., 2012). Similarly, the dramatic costs associated with healthcare and 
rehabilitation services may increase the likelihood that an examinee may put forth 
insufficient effort during assessments (Bigler, 2008). Indeed, this is documented, with as 
many as 58% of Veterans putting forth sub-optimal effort (Armistead-Jehle, 2010) and 
much of the variability (as much as 50%) in cognitive performance being explained by 
insufficient effort (e.g., Armistead-Jehle, 2010; Green et al., 2001; Nelson et al., 2010). 
As expected, individuals who fail PVTs perform poorer on cognitive testing than 
individuals who pass PVT, even after sustaining an MTBI (e.g., Jak et al., 2015; 
Stulemeijer et al., 2007). 
It is important to recognize that insufficient effort and PVT failure during 
neuropsychological evaluations are not limited to individuals with potential for secondary 
gain. PVT failure also frequently occurs in individuals experiencing emotional distress. 
For example, in a sample of patients with MTBI who were recruited from an ED and 
evaluated six months post-MTBI, 27% of the sample failed a PVT (Stulemeijer et al., 
2007). Those who failed a PVT did worse on almost all neuropsychological measures. 
Though, PVT failure was not associated with involvement in litigation, it was associated 
with higher emotional distress, greater negative affectivity (i.e., tendency to experience 
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distress), lower education, failing to return to work, and fatigue. Similarly, in a large 
sample of OIF/OEF Veterans who sought treatment for an MTBI, 30% of the sample 
failed at least one PVT (Jak et al., 2015). In addition, 74% and 85% of the individuals in 
the group that failed at least one PVT carried a clinical diagnosis of depression and/or 
PTSD, respectively. The prevalence of these disorders occurred at a significantly higher 
incidence rate relative to the group that passed all PVTs. Consistent with these general 
findings, individuals with a history of a mental health issues are four times more likely to 
fail one or more PVTs during an MTBI evaluation (Donders & Boonstra, 2007).  
In summary, issues unrelated to MTBI injury parameters can lead to poor effort 
during neuropsychological assessment and suppressed cognitive performance. Thus, it is 
crucial for clinicians to consider the possibility of insufficient effort when quantifying 
neurocognitive symptoms associated with MTBI and subsequent recovery.  
Summary of Effect Modifiers.  There are a multitude of factors that can 
potentially affect the neuropsychological recovery from an MTBI: population, age, 
psychological comorbidities, performance invalidity, to name a few. Yet, almost none of 
these issues are mutually exclusive. For instance, psychological comorbidities are not 
only found in Veterans, but can also be found in civilians. Performance invalidity is not 
limited to individuals involved in litigation. Athletes, who are typically motivated to 
return to play, may have maladaptive coping mechanisms or depressive personality 
characteristics that may increase the likelihood of prolonged cognitive recovery. None of 
these individual differences occur in isolation, but rather are complexly interwoven into 
multifaceted biopsychosocial mechanisms that can affect recovery (see Figure 1). Thus, it 
is extremely challenging to conduct empirical studies evaluating the intersection of these 
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individual differences. Rather, quantitative reviews of a multitude of studies may 
elucidate the unique contributions these individual differences make to cognitive 
recovery after sustaining an MTBI.  
Figure 1. 
Illustration of the Biopsychosocial Factors that May Affect Outcome After MTBI 
 
Note: MVA = Motor Vehicle Accident; SRC = Sports-Related Concussion; LD = 
Learning Disorder; ADHD = Attention Deficit/Hyperactivity Disorder; TBI = Traumatic 
Brain Injury 
 
MTBI Meta-Analytic Reviews  
 There is an emerging literature examining how individual differences might affect 
cognitive recovery after an MTBI, though there are discrepancies in these findings. Thus, 
there is a critical need for comprehensive quantitative analysis to integrate available 
research to elucidate the neuropsychological effects of sustaining an MTBI across broad 
populations. In brief, meta-analyses critically integrate and analyze the results of multiple 
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studies. Data from multiple studies are aggregated, “averaging” effect sizes reported in 
relevant studies. Relative to a single study, a meta-analytic review has increased power to 
detect a “true” effect if one exists (Bartolucci & Hillegass, 2010; Cohn & Becker, 2003). 
Furthermore, by pooling the results of multiple studies, meta-analyses often include a 
more heterogeneous pool of participants than a single study, which increases the 
generalizability of estimated effects (Bartolucci & Hillegass, 2010; Borenstein, Hedges, 
Higgins, & Rothstein, 2009). Several meta-analyses have been conducted examining the 
neuropsychological effects of sustaining an MTBI (See Table 2). While this body of 
literature has dramatically improved our understanding of MTBI, several notable 
methodological issues are present across studies and will be expanded upon below.  
 Binder, Rohling, and Larrabee (1997) conducted the first meta-analytic review to 
investigate the neuropsychological impact of MTBI. The review included 11 studies that 
examined mild head trauma (MHT; NMHT = 314; NControls = 308). All the studies were 
conducted at least 3 months post-injury and a small and non-significant overall effect size 
(i.e., estimated effect size of all cognitive constructs combined) was reported (Cohen’s d 
(d) = .12; Hedge’s g (g)= .07), suggesting no significant, negative cognitive effects of 
MTBI after three months. The researchers also examined whether MTBI might affect 
specific neuropsychological constructs and concluded that attention is mildly impacted (d 
= .20; g = .17) after 3 months or more. While this meta-analytic review is seminal in 
nature, there are some notable limitations that should be recognized. First, the number of 
included studies was relatively small (k = 11) and a single study contributed nearly half 
(51%) of the patients with MHT. In addition, considerable between-study statistical  
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Table 2.  
Summary of All Known Meta-Analyses Examining Neuropsychological Effects of MTBI 
First 
Author Year 
Population 
of Interest 
Total 
K Sub-group Comparison k d  
Binder 1997 Mixed 11 - 11 0.12* 
       
Frenchama 2005 Mixed 17 Acute (< 3 months) 12 0.33* 
    Post-Acute (> 3 months) 5 0.28 
    Total 17 0.32* 
       
Belanger 2005a Clinical/ 39 Litigation-based sample < 90 days 2 0.52* 
  
medical 
referrals  Litigation-based sample ≥ 90 days 6 0.78* 
    Clinic-based sample < 90 days - - 
    Clinic-based sample ≥ 90 days 11 0.74* 
    Unselected sample < 90 days 23 0.63* 
    Unselected sample ≥ 90 days 8 0.04        
Belanger 2005b Athletes  21 Within 24 hours: Self as control 5 0.44* 
    
Within 24 hours: Non-concussed 
control group 10 0.97* 
    1-7 days: Self as control 11 -0.08 
    
1-7 days: Non-concussed control 
group 11 0.43* 
    7+ days: Self as control 5 -0.65 
    
7+ days: Non-concussed control 
group 6 0.22* 
       
Pertab 2009 Mixed 18 > 3 months 18 -0.09 
       
Rohling  2011 Re-analysis 
of: 
Binder 
(1997) 
Frenchman 
(2005) 
Pertab 
(2009) 
48 < 7 days 16 0.39* 
   8-30 days 12 0.32* 
   31-92 days 4 0.14 
   > 93 days 16 0.17 
    All time points 48 0.28* 
       
Konigs 2012 Mixed 
      
21 < 6 months - FSIQ 3 0.08 
    > 6 months - FSIQ 2 -0.07 
    < 6 months - PIQ 4 0.12 
    > 6 months - PIQ 3 -0.05 
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    < 6 months - VIQ 3 -0.26 
    > 6 months VIQ 2 -0.36 
       
Green 
 
 
 
2013 
 
 
 
Mixed 
 
 
 
13 
 
 
 
Studies with AAN Methodology 
Rated I or II 
Studies with AAN Methodology 
Rated III or IV 
7 
 
5 
 
.52* 
 
.38* 
 
       
Dougan 2014a Athletes  91 
Aggregate across all comparison 
groups 40 0.54* 
    
Compared to baseline and control 
group 9 0.41* 
    Independent Control Group 7 0.59* 
    Pre-Injury Baseline Injury  24 0.55* 
       
Dougan 2014b Athletes 31 Grade 1 or 2 Concussion 2 0.23* 
    Grade 3 Concussion 12 0.63* 
Note. All effect sizes were converted to the same scale with positive effect sizes 
indicating worse outcomes; d = Cohens’ d; k = number of included studies; FSIQ = Full 
Scale IQ; PIQ = Perceptual IQ; VIQ = Verbal IQ; Effect sizes with asterisks indicate that 
the authors found the effect size to be significantly greater than zero 
Many of the included studies made other sub-group comparisons that were not listed 
 a Frenchman reported Hedge’s g, not Cohen’s d.  
 
heterogeneity was present, as evidenced by an extreme range of observed effect sizes (d 
ranged from -.41 to .82) and large standard deviations (SDd = .17; SDg = .18). 
Significantly, excessive between-study heterogeneity can impede ability to draw accurate 
conclusions (Greco, Zangrillo, Biondi-Zoccai, & Landoni, 2013; Greenland, 1987). 
Furthermore, this heterogeneity suggests the possibility that effect modifiers, or 
covariates, are likely to be contributing to variability between studies.  
 Approximately 10 years later, Frenchman, Fox, and Mayberry (2005) updated 
Binder and colleagues’ (1997) meta-analysis by including seventeen additional studies. It 
was determined that MTBI has a small negative overall effect on neurocognitive 
functioning (g = .32). This study also considered whether time since injury moderated 
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changes in neurocognitive functioning. A moderate effect size (g = .33) was observed 
during the acute stages of recovery (< 3 months) and there was a small, non-significant 
effect size in the post-acute stage (g = .11). To analyze the effect of time, the researchers 
performed a subgroup comparison, stratifying the studies by the covariate, time (acute 
versus post-acute). Two separate estimates of effect size, one for acute MTBI and one for 
post-acute, were computed. Although this approach is common in systematic reviews, the 
method of conducting multiple sub-group comparisons increases the risk of Type I errors 
(Cafri, Kromrey, & Brannick, 2010; Wang, Lagakos, Ware, Hunter, & Drazen, 2007). 
 Published the same year as Frenchman and colleagues’ (2005) meta-analytic 
review, Belanger and colleagues also examined the effects of time, as well as other 
possible moderators, on neurocognitive outcomes post-MTBI (Belanger, Curtiss, et al., 
2005). Thirty-nine articles published between 1970 and 2004 were identified that 
examined the neurocognitive effects of sustaining an MTBI in a medical-seeking 
population (i.e., non-athletes). The authors reported a medium overall effect size (d = 
.54), with small to medium effect sizes across nearly all cognitive domains. To explore 
the potential influence of additional moderators, sub-group analyses were conducted by 
stratifying neurocognitive domains by time post-injury (< 90 days, ≥ 90 days) and sample 
characteristics (litigation-based samples, clinic-based studies, unselected sample studies). 
These analyses showed that, generally, for the non-litigant studies, the effect sizes failed 
to reach significance after 90 days, whereas the effect sizes for the litigant-based studies 
tended to increase over time. While the researchers’ decision to stratify the sample by 
post-injury time intervals and sample selection shed invaluable insight into the 
differences in recovery across different populations, the Q statistic (a measure of 
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between-study heterogeneity) still reached significance across most of these sub-group 
analyses, suggesting not all meaningful moderators were explored. Furthermore, the 
process of stratification meaningfully depleted the number of studies included in each 
sub-group analysis. For example, only two studies included a litigation-based sample in 
the acute recovery period, which calls into question the precision of the observed effect 
size.  
 Belanger and Vanderploeg (2005) conducted an additional meta-analytic review 
analyzing the effects of MTBI on athletes. A medium effect size was observed across all 
cognitive domains (d = .49). They also investigated the moderating effect of time by 
performing three subgroup analyses during the acute period of recovery (within 24 hours, 
1-7 days, and beyond 7 days). Unlike the medical-seeking population from the previous 
analysis, the neurocognitive effects of MTBI resolved in nearly all domains after seven 
days for the athlete populations included in this study. In addition, likely due to a practice 
effect, studies that utilized a pre-post comparison design resulted in effect sizes nearly 
half as large as the effect sizes derived from studies using a non-concussed control group.  
Notably, again, these sub-group analyses resulted in a smaller number of studies included 
in each analysis and the Q statistic remained significant, suggesting the influence of 
additional moderators.  
 Several additional meta-analytic studies have examined the neuropsychological 
effects of sustaining an MTBI in various populations (Green, 2013; Konigs, de Kieviet, & 
Oosterlaan, 2012; Pertab, James, & Bigler, 2009; Rohling et al., 2011). Generally, 
researchers have found that cognitive residuals resolve in less than three months post-
injury. However, various moderator variables (e.g., litigation status, study methodology) 
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result in different effect size estimates. Despite attempts to explore these moderator 
variables, significant between-study heterogeneity generally remains, even when multiple 
subgroup comparisons are made (e.g., Belanger, Curtiss, et al., 2005). Thus, the field 
would benefit from an updated analysis that further explores moderator variables and 
attempts to control for between-study heterogeneity.  
Meta-Regression 
Meta-analytic methodologies are continuing to evolve and may be useful in 
addressing some of the issues previously described. Specifically, meta-regression 
analysis (Stanley & Jarrell, 1989) can control between-study heterogeneity, 
systematically test the significance of effect modifiers, or covariates, and quantify their 
effect on the effect size estimator. This method would address several limitations 
associated with prior meta-analytic reviews of MTBI, such as the significant between-
study heterogeneity and the decrease in k due to multiple sub-group comparisons.  
Similar to meta-analytic reviews, meta-regression has increased power to detect 
small effect sizes and yields results that are more likely to generalize than findings from a 
single study. The clear advantage of meta-regression is the ability to control for 
significant between-study heterogeneity. This is done by investigating whether covariates 
meaningfully impact effect size differences in regression models. Thus, researchers can 
simultaneously consider the effect of the covariates on neurocognitive recovery without 
having to conduct subgroup comparisons. As an example, a meta-analysis examining the 
relative risk of contracting tuberculosis (TB) after inoculation with a BCG vaccine 
included 13 studies and identified that the risk ratio of contracting TB was 0.65 (Colditz 
et al., 1994). Considerable heterogeneity was present among the studies and risk ratios 
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varied from .20 to 1.56 (Q(12) = 152.23, p < .0001). It was hypothesized that the vaccine 
would be more effective in colder climates because individuals living farther away from 
the equator would have a weaker, natural immunity to TB. A meta-regression was 
conducted to further explore this issue with latitude identified and added as a covariate to 
the model (Berkey, Hoaglin, Mosteller, & Colditz, 1995). Latitude was a significant 
covariate with the risk ratio of contracting TB with a BCG vaccine decreasing in 
effectiveness as distance from the equator increased. Remarkably, latitude accounted for 
79% of the between-study heterogeneity. Meta-regression methods are also useful in 
examining the magnitude a study characteristic has on an effect size. For example, a 
meta-regression was conducted to examine the dose-response effect of prophylactic 
aspirin and secondary stroke prevention (Johnson et al., 1999). The authors investigated 
if the relative risk of secondary stroke was altered with different doses of aspirin in a 
single analysis, rather than performing multiple subgroup analyses based on dose-size. 
The authors found that a flat (i.e., linear) dose-response curve in stroke prevention 
suggests that all doses of aspirin in the model similarly prevented subsequent strokes.  
To date, only one study has examined the neurocognitive effects of MTBI 
utilizing meta-regression to address issues associated with between-study heterogeneity 
(Dougan, Horswill, & Geffen, 2014). Overall, Dougan and colleagues’ analyses (k = 91) 
identified a small to moderate decrease in neuropsychological functioning (d = .40), 
moderate to large increase in self-reported symptoms (d = .66), and a small effect in 
balance disturbance (d = .11) was associated with concussion.1 Meta-regression analyses 
 
1 The study reported negative effect sizes to represent greater dysfunction. However, the direction of the 
effect sizes were reversed to remain consistent with the direction of the effect sizes reported in the previous 
studies. As such, the direction of the beta values for the reported regression were also reversed.  
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were conducted separately to control for time since injury, age, and education. The first 
regression analysis showed that the overall dysfunction associated with a concussion 
decreased over time (β = -.06), which suggests that a moderate to large effect of 
concussion would be observed in the first 24 hours but would decrease to a small to 
moderate effect after 10 days. This analysis, however, did not account for all the 
between-study heterogeneity and the Q statistic remained significant. Negative 
relationships between the neuropsychological effects of concussion and age (β = -.11) 
and education (β = -.20) were additionally reported. After controlling for these variables, 
the between-study heterogeneity reported in these two analyses (i.e., Cochran’s Q) was 
no longer significant. While this study is the first of its kind to use a meta-regression to 
better explain changes in neuropsychological functioning after MTBI, only a SRC 
literature was analyzed. Thus, our understanding of the neuropsychological effects of 
sustaining an MTBI would further improve if a more inclusive meta-regression were 
conducted that included a broader literature and considered additional moderator 
variables.  
Present Study 
 MTBI is a significant public health crisis, affecting millions of individuals in the 
US each year (Faul et al., 2010). There is considerable variability in presentation and 
duration of the cognitive, physical, and emotional symptoms that occur post-MTBI. 
Furthermore, there are cognitive, psychological, emotional, and demographic factors that 
potentially influence the extent of dysfunction and the duration of recovery (e.g., Fann, 
Uomoto, & Katon, 2001; Goleburn & Golden, 2001). Given the range of individual 
differences that could potentially affect MTBI recovery, a well-conducted quantitative 
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analysis of a broad literature would be of great value to clinicians and researchers. While 
several meta-analyses have been conducted examining the cognitive effects of MTBI (see 
Table 2), these studies have some notable methodological limitations (e.g., between-study 
heterogeneity, decreased power due to multiple sub-group comparisons). Meta-analytic 
regression addresses some of these limitations and may be useful in understanding how 
individual differences affect cognitive recovery after an MTBI. 
 A comprehensive, updated meta-analytic review was conducted that incorporated 
the largest number of published studies pertaining to MTBI, to date. Furthermore, this 
research utilized meta-regression techniques to control between-study heterogeneity and 
systematically test the direct influence of effect modifiers. The information garnered from 
these analyses has the potential to inform clinical care by establishing patient prognosis 
based on a host of individual differences. 
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Primary Aims 
Aim 1: Conduct an updated meta-analysis examining the neuropsychological effects of 
sustaining an MTBI across heterogeneous populations.   
 A significant body of literature makes clear that the acute neurocognitive effects 
of a single MTBI largely diminish three months post-injury (e.g., Belanger, Curtiss, et al., 
2005). Yet, several factors may contribute to documented variability in recovery. Thus, a 
primary aim of this study is to conduct an updated meta-analysis to elucidate how effect 
modifiers (e.g., population, age, psychological comorbidities, and performance invalidity) 
may affect MTBI recovery.  
Hypothesis 1: Consistent with the previous literature, a medium overall effect is expected 
in the acute period post-MTBI that will fail to reach significance after three months. 
Hypothesis 2: It is expected that (a) effect sizes will differ across the different 
“populations;” (b) effect sizes will not differ for the different age groups (c) effect sizes 
will differ for individuals with psychological comorbidities (d) effect sizes will differ for 
studies where effort testing is implemented 
Hypothesis 3: Despite stratifying by these different effect modifiers and performing 
multiple sub-group analyses, it is hypothesized that between-study heterogeneity will still 
exist. 
Aim 2: To conduct a meta-regression to control for potential between-study heterogeneity 
and quantify the effect of covariates has on the neuropsychological functioning post-
MTBI.  
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 Previous meta-analyses have documented that between-study heterogeneity is 
evident despite efforts to control for this variability via multiple sub-group comparisons. 
Thus, a meta-regression will be useful to examine the neurocognitive effects of sustaining 
an MTBI while controlling for this potential variability. Additionally, it will allow for the 
systematic testing of each effect modifier to determine if specific covariates affect 
estimated effect sizes. If so, the meta-regression will quantify the extent that each 
covariate affects the estimated effect size.  
 Consistent with Hypothesis 2, it is hypothesized that time since injury, 
psychological comorbidities/psychological functioning, and the utilization of PVTs will 
affect the estimated effect sizes of neuropsychological dysfunction post-MTBI. However, 
as outlined in the sections above, the unique between-study differences in findings across 
populations may be a result of the intersection of external (e.g., secondary gain) and 
internal factors (e.g., psychological comorbidities/psychological functioning). Thus, once 
the unique variance of time since injury, psychological comorbidity, and PVT testing are 
controlled, group membership (i.e., population) may not be an important predictor of 
MTBI outcome.  
Hypothesis 4: When entered into a meta-regression, time since injury, psychological 
comorbidities, and PVT testing will be significant covariates. Effect sizes are expected to 
decrease over time but increase in the presence of psychological comorbidities and 
increase if PVTs are not implemented. Whereas, population and age will not reach 
significance. 
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Methods 
Institutional Review and Best Practice Guidelines  
The present study did not require direct intervention or interaction with human 
subjects, nor was personal, private information identifiable during the systematic review 
process. Therefore, this study was exempt from institutional review (Electronic Code of 
Federal Regulations, 2018; Part 46 – Protection of Human Subjects). In accordance with 
best-practice guidelines, the study was prepared in accordance with the PRISMA 
statement guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009). Search criteria, 
selection criteria, and proposed analyses were pre-registered on a publicly available, 
online database (PROSPERO Registration Number:  CRD42018099719). 
Literature Search and Inclusion Criteria 
 Consistent with previous meta-analyses (e.g., Belanger, Curtiss, et al., 2005; 
Dougan et al., 2014), the internet databases PsychINFO, Medline, and PUBMED were 
utilized to identify relevant studies. To maximize the number of pertinent articles and 
decrease the number of non-relevant studies, key terms were entered into the databases as 
follows: (“Mild Traumatic Brain Injury” OR “MTBI” OR “Concussion” OR “Mild Head 
Injury”) AND (Neuropsycholog* OR Assess* OR Evaluat* OR Cogniti*)2. Furthermore, 
to ensure pertinent articles were not overlooked, the reference from prior MTBI meta-
analyses were also reviewed. The initial literature search was conducted November 2017. 
 
2 The asterisk (*) at the end of the truncated search term allows for the simultaneous search of multiple 
iterations of the word. For example, neuropsych* searchers for neuropsychology and neuropsychological. 
  33 
 
Table 3. 
Inclusionary and Exclusionary Criteria for Article Selection 
 
Briefly, empirical studies were included if an MTBI occurred and well-validated 
neuropsychological assessments were utilized to document cognitive functioning within 
three years from the initial injury. Articles were excluded if there was insufficient 
information to calculate or estimate effect sizes (See Table 3 for full inclusionary and 
exclusionary criteria). Additionally, if data for all cognitive outcome measures were not 
reported, the study was excluded. That is, studies were excluded if the authors only 
provided data for the significant, but not the non-significant findings. If assessments took 
place across multiple timepoints and the authors did not report the data from all time 
Inclusionary Criteria: 
• Published in English 
• Involved human research subjects 
• MTBI or concussion was clearly defined and consistent with the ACRM, WHO 
Task Force, or International conference on Concussion in Sports criteria 
• Included if the neuropsychological performance of an MTBI group is compared 
to pre-injury self, non-concussed control group, or orthopedic injury or pain 
control group 
• Included if the study utilized standardized and validated neurocognitive 
measures (e.g., Lezak, 1995; Strauss, Sherman, & Spreen, 2006) to assess 
cognitive functioning 
Exclusionary Criteria: 
• Insufficient information to calculate effect sizes 
• Average age of participants is not provided 
• Sample size of each group is less than 10 
• Case study 
• Non-empirical study 
• Meta-analysis  
• Systematic review 
• Intervention study 
• Participant recruitment based on neuropsychological normality or impairment 
• If average time since injury is not reported or if average time since injury of the 
study participants is greater than three years 
• If sample includes subjects with complicated (e.g., intracranial hemorrhage, 
skull fracture) TBI 
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points, the study was retained so long as all data were provided for at least one time 
point. 
Data Extraction and Evaluation of Inter-rater Reliability  
 Three supervised graduate students (DM, MN, KR) conducted an initial screening 
by reviewing titles and abstracts of articles obtained from the initial online search for 
inclusionary/exclusionary criteria. To increase inter-rater reliability, a training session 
was conducted to establish systematic and consistent screening and reviewing of article 
titles and abstracts (See Appendix A for flowsheet outlining the approach to abstract 
coding). A subset of articles were double-coded to establish inter-rater reliability. Of the 
492 articles (8.2%) that were double-coded, inter-rater reliability was strong (kappa = 
.887). Discrepancies and uncertainty in article coding were resolved via a consensus 
conference among the reviewers and a licensed psychologist (JH).  
 After initial review of the articles, the full text documents were further screened 
for inclusion/exclusion criteria. This process was completed by the primary investigator 
(DM). The same reviewers and licensed psychologist took part in data extraction, effect 
size calculation, and identification of moderator variables once an article was identified 
as meeting full inclusionary/exclusionary criteria. All extracted data utilized for effect 
size calculations were double coded for accuracy by supervised research assistants.  
Variables of Interest 
 While this study was inherently exploratory in nature, all variables of interests 
were selected a priori and listed with the open-access systematic review registry, 
PROSPERO. This was done to reduce potential bias and prevent p-hacking (i.e., 
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conducting multiple analyses until statistical significance was found). Variables of 
interested are detailed below.  
Cognitive Outcome Measures. Consistent with previous meta-analyses 
(Belanger, Curtiss, et al., 2005; Belanger & Vanderploeg, 2005; Dougan et al., 2014; 
Frencham et al., 2005; Rohling et al., 2011), tests were grouped in a manner that is 
consistent with neuropsychological literature (Lezak, 1995; Strauss, Sherman, & Spreen, 
2006). Nine outcomes based on cognitive domains were created: (1) general ability/IQ; 
(2) orientation; (3) language abilities/academic achievement; (4) attention/working 
memory; (5) processing speed; (6) executive functioning; (7) immediate memory; (8) 
delayed memory; (9) fine motor movement. The effect sizes of all cognitive outcome 
measures were also aggregated via arithmetic mean to create a single, “Overall” effect 
size to represent the total cognitive sequalae of sustaining an MTBI.  
 Diverging from the precedent of most other MTBI meta-analyses (c.f., Pertab et 
al., 2009), only validated neurocognitive assessments frequently used in clinical practice 
that measured the cognitive domains outlined above were selected for analysis . This was 
done to increase the internal consistency within cognitive domains. In addition, this 
ensures that a lack of between-group differences in cognitive recovery does not reflect 
experimental test construction and unknown psychometric properties. For example, in an 
imaging study conducted 37 days post-injury, performance differences were not observed 
between patients medically referred for treatment of MTBI and a control group for a 
working memory task used during neuroimaging; however, in the same study significant 
differences were found in a well-established task of attention and working memory 
(McAllister et al., 2011). A measure was considered “validated” if (1) the measure is 
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referenced by well-established sources of psychological assessment (Lezak, 1995; Strauss 
et al., 2006); or (2) if relevant validity studies have been published in referred journals. If 
a study included both validated and non-validated assessment measures, the study was 
retained and only the validated measures were included in the analysis.    
Moderator Variables. This study sought to determine if effect modifiers, or 
covariates, affect cognitive recovery from MTBI. Specifically, the primary covariates of 
interest are: time post-MTBI, population (e.g., athletes, Veterans, general medical 
referrals, litigants), age, psychological comorbidities, and if the study used PVTs to 
exclude non-credible performance. Given that Aim 1 analyses utilize categorical 
variables, continuous moderator variables were also coded categorically for these 
analyses (See Appendix B for the data code sheet for additional information).  
Time since Injury. For pair-wise comparisons (Aim 1), time since injury was 
coded categorically into five discreet time strata: 1) ≤ 24 hours; 2) 1-8 days; 3) 9-30 days; 
4) 31-90 days; and 5) > 90 days. These timepoints were selected for consistency with 
documented neurometabolic and neurophysiological recovery periods post-MTBI (Giza 
& Hovda, 2001), and with the assessment intervals commonly used within the empirical 
literature. The mean time since injury was coded as a continuous variable for meta-
regression analyses (Aim 2).  
It is common that studies report outcomes for multiple time points when the study 
participants are followed longitudinally. However, inclusion of multiple time points from 
a single study in a given analysis biases the overall calculation of the observed effect size 
as that study is given more weight than other studies with a single time point. It is 
uncertain, however, how multiple timepoints were handled in previous MTBI meta-
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analyses. To our best knowledge, previous studies created a single outcome by averaging 
these timepoints together. However, important variability regarding cognitive recovery is 
potentially lost by this method. For example, if a study found a large effect size (d = 1.00) 
in the first 24 hours after an injury and a small, non-significant effect size one year after 
the injury (d = .01), the mathematic average would give the potentially erroneous 
conclusion that a medium effect size (d = .50) was found after 6 months. To prevent 
studies with multiple outcomes from unduly biasing the overall results, only a single time 
point per time strata was utilized in each analysis 
 In an effort to reduce bias and preserve important variability, an arithmetic 
average across timepoints was not utilized. For Aim 1, multiple timepoints were analyzed 
separately based on their respective time stratum (i.e., ≤ 24 hours, 1-8 days, 9-30 days, 
31-90 days, and > 90 days). However, if a study reported multiple outcomes that fell 
within a given time strata, the furthest timepoint with (presumably) the smallest effect 
size was selected for analysis. For example, Kontos and colleagues (2016) reported 
outcomes for three time points within the “9-30 day” window (14 days, 21 days, and 28 
days). Therefore, the data from the furthest time point (28 days) was retained for pairwise 
analyses. 
 For Aim 2, time since injury was analyzed as a continuous variable. Therefore, 
multiple time points could not be analyzed separately. To avoid the issues involved with 
averaging multiple time points as done by other studies, only the furthest time point was 
retained for analysis. For example, Nelson and colleagues (2016) reported outcomes for 
four time points post-injury: < 24 hours, 8 days, 15 days, and 45 days. Only the data from 
45 days post-injury was retained for analysis. The rationale for selecting the furthest time 
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point was two-fold: (1) in the very acute stages of MTBI, the extent of cognitive 
dysfunction appears to be similar across populations (McCrea et al., 2014) and (2) a 
primary objective of this project is to determine moderating factors of cognitive recovery 
post-MTBI, and not necessarily the acute effects of sustaining an MTBI.  
Population. For both the pair-wise analysis and the meta-regression, population 
were coded as a categorical variable (Athlete, General Medical Referral, Veteran, and 
Litigant). While we acknowledge the inherent medicolegal nature of neuropsychological 
assessments with Veterans, any Veteran sample was coded as “Veteran” even if the 
sample consisted of individuals involved in a compensation/disability evaluation.  Even if 
it represented a minority of the participants, a study was coded as “litigant” if it included 
any participants who were involved in litigation or seeking compensation for their injury.  
Age. The average age of the study sample was coded in two ways: categorically 
(children, high school and college, adult, older adults; Aim 1) and as the mean age of the 
sample (Aim 2). Study samples with an average age of 0-13 years of age were coded as 
“children,” samples with a mean age between 14-22 were coded as “high school and 
college,” samples with a mean age between 23-64 were coded as “adults,” and samples 
with an a mean age of 65+ were coded as “older adults.”  
Psychological Comorbidity and Functioning. Similar to age, psychological 
comorbidities were coded both categorically (Aim 1) and continuously (Aim 2). If the 
entire sample had the presence of a psychological comorbidity, it was coded as “100% 
psychological comorbidity,” whereas, if the study explicitly excluded study subjects with 
psychological comorbidities, it was coded as “0% comorbidity.” Any sample percentage 
in between the two was be coded as “mixed.” If the study did not specifically state that 
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psychological comorbidities were assessed or screened, the study was conservatively 
labelled as “mixed.”   
If questionnaires assessing emotional well-being and personality were reported, 
the effect sizes of mood disturbance relative to the control group were calculated in the 
same manner as the cognitive constructs (see Effect Size Calculation for methodology). 
Initially, psychological functioning was stratified into separate psychological constructs 
(depression, anxiety, PTSD, SUD, somatization, internalizing behaviors, externalizing 
behaviors). While there may be different effects across various psychological constructs a 
single “Overall” psychological functioning variable was created to increase power and 
conciseness. This variable was intended to capture the overall extent of psychological 
distress experienced by the MTBI samples relative to the controls, and it was created via 
arithmetic mean of the effect sizes across psychological constructs and is the primary 
moderator variable of psychological functioning for meta-regression analyses (Aim 2).   
Performance Validity Testing and Effort. Studies that utilized embedded and/or 
freestanding PVTs to identify and exclude study participants with sub-optimal task 
engagement were coded categorically (effort screened; effort not screened).  
Secondary Moderator Analyses. Much like simple linear regression, there must 
be a sufficient ratio of covariates to data points to include multiple moderator variables in 
an analysis. That is, it is recommended that there be at least 10 studies included in a 
meta-regression analysis for every covariate (Borenstein et al., 2009). As a result, this can 
limit the number of covariates considered. The following additional moderators were 
coded for supplemental, exploratory analyses.  
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Post-Concussive Symptomology: The presence of post-concussive symptomology 
(PCS) was coded in a continuous manner. An effect size of PCS symptomatology was 
calculated when questionnaires were given to both the MTBI and control groups (See 
Effect Size Calculations for methodology). 
Control group. The control group implemented by researchers may affect the 
observed outcomes (Belanger & Vanderploeg, 2005; Dougan et al., 2014). Some studies 
attempt to control for extraneous variables such as pain or psychological distress when 
assessing the cognitive sequelae of an MTBI. These studies tend to lead to a more 
conservative effect size estimate than studies that utilize healthy, non-injured participants 
as controls. Therefore, the type of control group (non-injured control, pre-injury baseline, 
non-injured control & pre-injured baseline, orthopedic injury, trauma, chronic pain) was 
documented.  
Injury Parameters. If provided by the author, the percentage of individuals who 
experienced LOC, post-traumatic amnesia, and/or a prior MTBI were also coded.  
Demographics. Given that demographic factors such as race (Shafi et al., 2007), 
sex (Bazarian, Blyth, Mookerjee, He, & McDermott, 2010), and education (Dougan et al., 
2014) may affect cognitive recovery, pertinent demographic information was also 
recorded when available.  
Effect Size Calculations 
 As most data from MTBI neuropsychological outcomes studies are continuous, all 
dependent variables were converted into the effect size, Cohen’s d, as is convention for 
  41 
 
studies in this field3 (Belanger, Curtiss, et al., 2005; Belanger & Vanderploeg, 2005; 
Binder et al., 1997; Dougan et al., 2014; Konigs et al., 2012; Pertab et al., 2009; Rohling 
et al., 2011; c.f., Frencham et al., 2005). If another effect size were provided (e.g., 
Pearson correlation, r), it was converted into Cohen’s d following standardized processes 
(Lipsey & Wilson, 2000). Likewise, in the absence of group means or calculated effect 
sizes, the inferential statistics reported by the authors may also be used to estimate the 
effect size (Lipsey & Wilson, 2000).  
Effect sizes were calculated in accordance with well-established methods outlined 
by Lipsey and Wilson (2000). Effect size calculation differed based on the study design 
utilized by the authors, which fell into one of three categories: 1) two independent groups 
2) repeated measures design and; 3) independent groups with repeated measures.  
Independent Groups, Post-Test Only. The standardized mean difference 
between two independent groups was calculated based on the following equation: 
𝑑 =  
𝑀𝐶𝑜𝑛𝑡𝑟𝑜𝑙 − 𝑀𝑇𝐵𝐼
𝑆𝐷𝑃𝑜𝑜𝑙𝑒𝑑
       (1) 
Where the 𝑆𝐷𝑝𝑜𝑜𝑙𝑒𝑑 is the pooled standard deviation and was calculated as: 
𝑆𝐷𝑝𝑜𝑜𝑙𝑒𝑑 =  √
(𝑛1−1)𝑆𝐷1
2+(𝑛2−1)𝑆𝐷2
2
𝑛1+ 𝑛2−2
    (2) 
The standard error of the effect size estimate (𝑆𝐸𝑑) was calculated as:  
 
3 While most meta-analyses in this field utilize Cohen’s d, there are some criticisms of this methodology as 
Cohen’s d is a biased effect size estimate (Lakens, 2013). Rather, some researchers report Hedges g as it 
attempts to correct for bias (e.g., Frenchman et al., 2005). However, when sample sizes are large (n > 20) 
the difference between the two effect sizes are negligible (Lakens, 2013). Given that we expect a large k 
with large sample sizes, we expect there to be no meaningful differences between Cohen’s d and Hedges g.  
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𝑆𝐸𝑑 =  √(
𝑛1+ 𝑛2
𝑛1 𝑛2
) + 
𝑑2
2(𝑛1+ 𝑛2)
     (3) 
Repeated Measures (Same Sample) Design. In this dependent-sample design, 
the post-injury scores of the participants are compared to their own pre-injury baseline 
scores, resulting in a standardized change score (compared to a standardized difference 
scores produced from the other designs). The formula for the standardized change is 
calculated as follows: 
𝑑𝑅𝑀 =  
𝑀𝑑𝑖𝑓𝑓
√𝑆𝐷1
2+𝑆𝐷2
2−2𝑟(𝑆𝐷1
2+𝑆𝐷2
2) 
 𝑥 √2(1 − 𝑟)   (4) 
where 𝑀𝑑𝑖𝑓𝑓 is the mean difference in scores between time 1 and time 2, and r is the 
correlation between time 1 and time 2. The standard error of 𝑑𝑅𝑀 is calculated by the 
following equation:  
𝑆𝐸𝑑𝑅𝑀 =  √(
1
𝑛
+  
𝑑2
2𝑛
) 2(1 − 𝑟)     (5) 
Notably, these formulas require both the average change scores as well as the correlation 
between the two time points, both of which are rarely provided by the authors. When 
correlations are not provided, it is recommended to estimate the correlation from similar 
studies (Borenstein et al., 2009). However, studies where such information are provided 
(i.e., test-retest reliability, reliable change studies) typically sample from a healthy, non-
injured pool of participants (c.f., Nelson, LaRoche, et al., 2016). Thus, those correlations 
are unlikely to resemble the true correlation in testing outcomes in an MTBI sample 
where the scores are expected to change across time.  
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Other formulas that do not require average change scores or correlations have 
been proposed (Becker, 1988; Morris & DeShon, 2002). These formulas utilize either the 
pre-injury standard deviation (Becker, 1988) or pool the standard deviations from both 
time points (Morris & DeShon, 2002). However, these methodologies have been found to 
result in larger estimated effect sizes (Belanger & Vanderploeg, 2005; Dougan et al., 
2014) and are susceptible to maturation and practice effects. Finally, most studies 
utilizing this design involved athletes; it is rare that baseline testing is obtained in non-
athlete populations. Thus, to ensure consistence in study designs across all populations, 
the formula proposed by Lipsey and Wilson (2000), which requires the correlation 
between the two time-points, was utilized. Notably, this methodological decision resulted 
in the exclusion of most of the repeated measures study designs.  
 Independent Groups with Repeated Measures. Likely the most robust 
experimental design, the pre-post design with independent groups accounts for any 
potential practice effects from repeated testing. The effect size is calculated by 
subtracting the standardized difference of the control group from the standardized 
difference of the injured sample via the following equation:  
𝑑 =  
(𝑀𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑇2− 𝑀𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑇1)− (𝑀𝑀𝑇𝐵𝐼 𝑇2− 𝑀𝑀𝑇𝐵𝐼 𝑇1)
𝑆𝐷𝑃𝑜𝑜𝑙𝑒𝑑 𝑇2
    (6) 
where 𝑆𝐷𝑃𝑜𝑜𝑙𝑒𝑑 𝑇2 is calculated the same manner as Equation (2); that is, the standard 
deviation is pooled from the MTBI and control group post-injury outcomes. The 𝑆𝐸𝑑 for 
the independent group with repeated measures design is calculated the same way as 
Equation (3) where the post-injury sample sizes are used.  
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Outlier Analysis  
 Publication bias, the non-random exclusion or absence of studies, can lead to 
outlying study effects. One source of publication bias is the small-study effect (Greco et 
al., 2013). The small-study effect occurs when smaller studies tend to systematically have 
different effect sizes than larger studies. This may be due to differences in methodology 
where smaller studies are less methodologically sound than larger, well-funded studies; 
or, due to a file-drawer effect, where smaller studies with null findings are less likely to 
be published (Greco et al., 2013). Due to the smaller sample size of these studies, there is 
greater variability which can lead to an inflation in reported effect sizes compared to 
larger studies (Sterne, Gavaghan, & Egger, 2000; Sterne, Egger, & Smith, 2008).  
To assess for publication bias, a funnel plot was constructed and visually 
inspected (Bartolucci & Hillegass, 2010).  A formal test of asymmetry in the funnel plot 
was conducted via Egger’s Regression Intercept (Egger, Smith, Schneider, & Minder, 
1997), which uses linear regression to measure the degree of bias seen from the small 
study effect. As asymmetry increases, the intercept of the line deviates from 0. This test 
determines if the intercept is significantly different from 0.   
To determine the extent that the file-drawer effect may be problematic, a Fail Safe 
File Drawer analysis (Rosenthal, 1979) was also calculated. This analysis calculates the 
number of unpublished studies necessary to offset the obtained effect size estimate. If a 
relatively small number of studies are needed to offset the obtained effect size, there is 
likely a file-drawer effect. However, if many studies are needed to offset the potential 
results, then a file-drawer effect is less likely.  
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Data Analysis   
 Effect sizes were derived from each study with an Excel program developed by 
the primary investigator (DM). This program incorporated the methodological 
calculations outlined by Lipsey and Wilson (2000) and is freely available to the public 
(https://www.marquette.edu/psychology/frl-neuropsychology-and-personality-lab.php). 
The pairwise and meta-regression analyses were conducted utilizing Comprehensive 
Meta-Analysis Version 3 software (Borenstein, Hedges, Higgins, & Rothstein, 2016).  
 Individual effect sizes from each study were aggregated and weighted based on 
the following equation:   
𝑑 =
∑ 𝑤𝑖𝑑𝑖
∑ 𝑤𝑖
       (7) 
where 𝑑𝑖 is the effect size estimate of a particular study and 𝑤𝑖 is the weighted variance. 
The way in which 𝑤𝑖 is calculated depends on whether a fixed-effect or a random-effect 
is being calculated.  
 Previously published MTBI meta-analytic studies conducted fixed-effect 
analyses. A fixed-effect meta-analysis assumes that there is one true effect size and the 
various studies included in the analysis are estimating that effect size. It assumes that the 
included studies are a random sample of a relevant distribution of effects, and that the 
calculated effect size is an estimate of the mean effect of said distribution. Furthermore, 
all factors that could potentially influence the effect size are the same across all study 
populations (Borenstein et al., 2009). Thus, the only source of error observed when 
calculating the overall weighted effect size is the random error found within studies. In 
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contrast, the current study conducted random-effects analyses. A random-effects model 
assumes that the true effect size varies from study to study (Borenstein et al., 2009). The 
studies included in the meta-analysis are assumed to be a random sample from a relevant 
distributions of true effects, rather than a distribution of a single effect, as in the case of 
fixed-effects. Thus, there are two sources of error: the within-study error and between-
study error.   
 All prior MTBI meta-analyses conducted fixed-effect analysis (e.g., Dougan et 
al., 2014). However, the purpose of the present study is to determine the extent that 
moderator variables (i.e., population, age, psychological comorbidities, PVT 
performance) affect cognitive recovery after sustaining an MTBI. It was hypothesized 
that some of these modifiers would influence the overall effect of an MTBI. It would be 
illogical, therefore, to conduct a fixed-effect meta-analysis given that we do not assume 
there is one “true” effect size associated with MTBI. Thus, a random-effects meta-
analysis was selected as the primary analytical method. The rest of this section elaborates 
upon methodological issues that are specific to each Aim.  
 Aim 1. An updated meta-analysis examining the neuropsychological effects of 
sustaining an MTBI across heterogeneous populations was conducted. Consistent with 
the approach utilized in prior MTBI meta-analyses, multiple sub-group comparisons were 
conducted. A random-effects analogue-to-ANOVA was conducted to examine 
differences in observed effect sizes across cognitive domains (e.g., processing speed, 
immediate memory, executive functioning), populations (athletes, general medical 
referrals, Veterans, litigants), ages (children, high school and college, adults, older 
adults), the presence of psychological comorbidity (none, mixed, 100%), and if effort was 
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systematically evaluated. Multiple comparisons were made to determine if the estimated 
effect size is significant in the acute phases (≤ 24 hours,1-8 days), sub-acute phases (9-30 
days, 31-90 days) and the post-acute phase (> 90 days) after sustaining an MTBI.  For the 
sake of parsimony and to reduce Type I errors, all moderator analyses were conducted 
utilizing the Overall cognitive functioning variable.  
 To assess for between-study heterogeneity, or a wide distribution of observed 
effect sizes not due to chance, Cochran’s Q was calculated. Cochran’s Q, which follows a 
Chi square distribution is calculated as follows:   
𝑄 = ∑ 𝑤𝑖(𝑑𝑖−?̅?)
2    (8)  
where ?̅? is the mean calculated effect size and 𝑑𝑖 is the effect size of the ith study. A 
smaller Q statistic suggests a lack of heterogeneity (Bartolucci & Hillegass, 2010) 
whereas a larger Q statistic suggests that the variability in observed effect sizes cannot be 
explained by random sampling error, alone. Notably, some researchers posit that due to 
differences in methodology and the demographic composition of various studies, 
heterogeneity is inevitable (Higgins, Thompson, Deeks, & Altman, 2003). Thus, another 
index for heterogeneity is 𝐼2, which measures the impact of the heterogeneity on meta-
analytic results, rather than attempting to detect it as Cochran’s Q does. This variable, 
which ranges from 0-100, provides an estimate of the variability that remains 
unexplained after the analysis. 𝐼2 was calculated as follows:  
𝐼2 = (
𝑄−𝑑𝑓
𝑄
) ∗ 100       (9) 
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where higher values of 𝐼2 indicates more variability in effect size estimates due to 
heterogeneity, rather than random, sampling error.   
 Aim 2. A random-effects meta-regression was conducted, which was modelled as 
follows:  
𝑦𝑖 =  𝛽0 +  𝛽1𝑥1𝑗 +  𝛽2𝑥2𝑗 + ⋯ 𝛽𝑖𝑥𝑖𝑗 +  𝜀𝑗 +  𝜂   (10) 
Where 𝑦𝑖 is the effect size for the ith study and 𝛽0, the Y intercept, is the estimated 
overall effect size when the covariates are not considered (Berkey et al., 1995). The 
covariates, 𝛽𝑖, have the value 𝑥𝑖𝑗 for each study, j. The error terms, 𝜀𝑗 represents the 
imprecision of estimating the effect size for each study, j (i.e., sampling error).  𝜀𝑗 ~ N(0, 
𝜎𝑗
2) where 𝜎𝑗
2 is the within-study variance and used to estimate 𝜀𝑗. The between-study 
variability for the jth study is 𝜂𝑗. 𝜂𝑗 ~ N(0, 𝜏
2) where 𝜏2 is the is the true effect size 
across studies and used to estimate between-study variable. Therefore, in a random-effect 
analysis, the observed effect size has the following distribution: 𝑦𝑖 ~ N(𝑋𝑗𝛽, 𝜏
2 + 𝜎𝑗
2). 
  Based on methodology of similar meta-regressive studies (Etnier, Nowell, 
Landers, & Sibley, 2006; Lee, Hermens, Porter, & Redoblado-Hodge, 2012), each effect 
modifier was modeled, separately, with mean time since injury as a covariate. That is, 
population, average age of sample, the effect size of psychological and personality 
questionnaires, and PVT testing were modeled separately after controlling for the mean 
time since injury. Significant of covariates was determined via Knapp-Hartung instead of 
a Z-test as the Knapp-Hartung is more conservative, yet more accurate when using 
random-effects analyses (Knapp & Hartung, 2003). Significant covariates were then 
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entered into a meta-regression simultaneously. To further examine neurocognitive 
recovery curves over time, linear and non-linear (quadratic) models were also conducted.  
The variability explained by each predictor was calculated. Much like the 
coefficient of determination in simple linear regression (i.e., 𝑅2), this metric was 
calculated by finding the ratio of the variance explained by the covariate and the total 
variance. However, the covariates are study-level covariates, thus only providing a 
measure of the between-study variability. Thus, to provide a better metric, the 𝑅2 will 
reflect a ratio of the “true” variability (i.e., between- and within-study variability) 
(Borenstein et al., 2009), 𝜏2:  
𝑅2 =  
𝜏𝐸𝑥𝑝𝑙𝑎𝑖𝑛𝑒𝑑
2
𝜏𝑇𝑜𝑡𝑎𝑙
2      (9) 
 Power Analysis 
 A priori power analyses were conducted with R statistical packages (R Core 
Team, 2014) using a script (Quintana, 2016) that utilizes the formulas for random-effects 
meta-analytic power analyses outlined by Valentine, Pigott, and Rothstein (2010). Based 
on previous meta-analyses, large between-study heterogeneity was assumed for the 
power analyses. Table 4 displays the combination of different number of studies (k) and 
average number of MTBI and control participants needed to detect a small effect size (d 
= .20) with at least 80% power.  
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Table 4 
Power Analysis Displayed Minimum Number of Effects and Participants Needed to 
Attain Sufficient Power to Detect a Small Effect Size  
 
Number of 
Effects 
Average n 
Per Group Power 
30 55 0.82 
35 45 0.80 
40 40 0.81 
45 40 0.84 
50 35 0.84 
55 30 0.82 
60 30 0.85 
65 25 0.81 
70 25 0.84 
75 25 0.84 
80 20 0.81 
85 20 0.83 
90 20 0.85 
95 20 0.86 
100 20 0.88 
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Results 
 The initial article search across databases (PsychINFO, PubMed, MedLine) 
identified 8,697 studies for potential inclusion. Another 297 articles were identified from 
previously published meta-analyses (38 of which were unique and not duplicates with the 
primary literature search). After duplicates were removed, 6,010 titles and abstracts were 
screened for potential inclusion. Of these articles, 5,361 were excluded, leaving 649 
articles whose full text was reviewed for possible inclusion (Figure 2). 
Figure 2. 
Flow of Meta-analysis Search and Application Inclusion Criteria  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Articles Identified Through Database 
Searching:  
PsychINFO = 3,360  
Medline = 1,141 
PubMed = 4,196 
 
Total Articles: 8,697 
Number of Articles Identified through 
other sources:  
 
297 articles identified from 9 
previously published meta-analyses 
pertinent to MTBI 
2,616 Duplicate Articles Removed 
6,010 citations (titles and abstracts) 
screened for relevance  
 
5,361 Excluded 
*Animal study - 39 
*Case Study/Case Series – 207 
*Commentary/Editorial – 146 
*Duplication – 107 
*Insufficient Information/Incomplete 
Citation – 177 
*Intervention/Experimental Study – 149 
*Lack of Appropriate Control Group – 
718 
*Mean Time Since Injury > 3 yrs – 8 
*MTBI Did Not Occur – 465 
*MTBI Not Defined – 42 
*MTBI Not Primary Focus of Study – 585 
*N < 10 for each group – 28 
*No Neuropsychological Assessment – 
1248 
*Not an Empirical Study – 1245 
*Systematic Review/Meta-Analysis – 197 
 
 
 
 
 
649 Full Text Articles Randomly 
Sampled and Assessed for Full Text 
Eligibility  
 
345 Excluded 
 
*Data included in another study - 
3 
*Article cannot be located – 1 
*Effect size cannot be calculated 
– 109 
*Insufficient information to 
calculate effect size – 45 
*Intervention Study – 4 
*Lack of Appropriate Control 
Group – 31 
*Time Since Injury Not Reported 
– 26 
*Mean Time Since Injury > 3 
years – 3 
*MTBI Did not Occur – 13 
*N < 10 – 13 
*No Neuropsychological 
Assessments – 9 
*Non-standardized 
Neuropsychological Assessments 
– 32 
*Not an Empirical Study – 4 
*Presence of Complicated MTBI 
– 36 
*Unselected Study Sample – 12 
*Participants Selected Based on 
Cognitive Abnormality - 3 
 
K = 195 Athlete & General 
Medical Referral Studies Not 
Further Evaluated for 
Inclusion/Exclusion Criteria  
 
K = 109 Studies Included for Analysis 
(125 independent samples) 
 
k = 45 General Medical Referrals 
k = 45 Athletes 
k = 14 Litigant  
k = 5 Veterans  
 
  52 
 
Despite careful cultivation of search terms and stringent inclusionary and 
exclusionary criteria, the recent explosion in the MTBI literature resulted in a much 
larger pool of potential studies than anticipated. For example, the final sample of studies 
aggregated across all sources was nearly six times larger than the largest MTBI meta-
analysis published to date (1,243 vs. 6,010; Dougan et al., 2014). Similarly, there were 
200 more papers whose full text was reviewed for inclusionary criteria compared to the 
largest previous meta-analysis (420 vs. 649). In order to limit the scope of the project, 
while maintaining an ability to evaluate primary aims and maintain adequate power, the 
decision was made to randomly select studies for detailed review until a pre-determined 
number (k = 45) of studies for each population sub-group met inclusionary criteria. 
Articles were selected based on population (rather than other moderator variables of 
interest) as a primary aim of the study was to discern moderator variables the explain the 
well-established differences in cognitive recovery across various populations (e.g., athlete 
vs. GMR; GMR vs. litigants). The decision to randomly sample articles to review was 
made after consultation with a meta-analytic expert who advised on study methodology 
(Jackson, 2018, personal communication, May 17, 2018).  While this methodology is 
novel, it is defensible as a random effects meta-analysis assumes that the effects included 
in the analyses are a random distribution among the true population effect. Therefore, by 
randomly selecting articles for inclusion, we maintain the randomness of the distribution 
among the true population effect4. As such, 45 articles met full inclusionary criteria for 
the athlete and general medical referral (GMR) groups. However, only 14 studies with 
individuals involved in litigation and 5 studies with Veterans met full criteria. In total, 
 
4 This methodology deviated from the analyses that were initially proposed and registered with 
PROSPERO 
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109 studies met full criteria for inclusion in analyses. Fifteen studies provided data for 
multiple, independent samples, yielding a total of 125 independent samples included in 
the analyses (NMTBI = 5,919, NControl = 8,318). Across all studies, sub-groups, and time 
points, 747 outcomes were extracted for analysis. Table 5 displays the characteristics of 
the included studies.  
Outlier Analysis and Publication Bias 
 Extreme Scores. The distribution of all 747 effect sizes from all 125 samples 
were analyzed for outlying data points. Any effect size more than 3 standard deviations 
from the mean of all observed effect sizes (-1.97, 2.81) were considered outliers (Dougan 
et al., 2014; Hedges & Olkin, 1985; Lipsey & Wilson, 2000). Eight effects were 
identified as outliers, originating from three studies (McCauley et al., 2014; Moser, 
Schatz, & Jordan, 2005; Roebuck‐Spencer et al., 2012). One outlier was in the negative 
direction (d = -2.05 7 days after injury; Moser et al., 2005) and the remaining seven were 
in the positive direction (d ranged 3.69 to 11.48, 2 days and 404 days post-injury; 
Roebuck-Spencer et al., 2012; McCauley et al., 2014). The data from McCauley (2014) 
were not true marginal means, but rather means after adjusting for age, sex, and 
perceived stress. In Moser (2005) only a single effect, measuring language, was found to 
be an outlying effect. In the study completed by Roebuck-Spencer (2012), the study was 
an independent sample with repeated measures. The effect sizes were extreme, in part, 
because the control group showed significant improvement with repeated testing, 
whereas the MTBI groups showed significant declines. Rather than excluding these 
studies, the effect sizes were reduced to the next major cluster of non-outlying effect 
sizes (Lipsey & Wilson, 2000).
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Sample Country Population n MTBI n Control
Control 
Group
Age
Mean   
Education
%  
Female
% 
Previous 
MTBI
% 
LOC
% 
PTA
Psych 
Comorbidity 
PVTs TSI (days) d
7 0.016
90 0.035
Pontifex (2009) USA Athlete 30 36 NIC 19.9 14.2 23 100 53 50 Mixed No 1044 0.2
Elbin (2012) USA Athlete 14 14 NIC    100   Mixed No 278.7 0.168
Gardner (2010) Australia Athlete 34 39 NIC 23 13.36 0 100   0 No 560.1 0.227
Singh (2014) USA Athlete 25 25 NIC 21.16 13.44 0    0 No 270.6 0.088
Moser (2002) USA Athlete 13 13 NIC 16.36  21    Mixed No 7.5 0.377
Mrazik (2016) Canada Athlete 63 31 NIC & PIB 21.8 14.2 0    Mixed No 10 -0.457
Guskiewicz (1997) USA Athlete 11 11 NIC 18.6  27.7 0 54.5 18.18 Mixed No 1 0.444
Tsushima (2013) USA Athlete 26 25 NIC 15.42 9.23  0   Mixed No 6.8 0.207
Koehl (2016) USA Athlete 29 25 NIC 14.41 8.1 20.7 31 44.8 44.8 0 No 53.79 0.853
0.54 0.28
49 0.023
Sim (2008) USA Athlete 14 14 NIC & PIB 15.5  21.42 42.86 14.28 28.57 Mixed No 6.3 0.817
Sikoglu (2015) USA Athlete 14 13 NIC 20.1  35.71 57.14 0  0 no 76.45 0.629
Moser (2005) USA Athlete 25 82 NIC 15.8 10.5  40   Mixed No 7 -0.087
McCrea (1998) USA Athlete 33 568 NIC   0  0 0 Mixed No 0.01 1.1
Hutchison (2011) Canada Athlete 36 18 OI 19.78  67 36   0 No 3 0.189
Moore (2017) Canada Athlete 14 16 NIC 23.36 17.29 0 100 0 28.57 0 No 819 0.186
Baillargeon (2012)g Canada Athlete 15 15 NIC 23.4 16.1 0    0 No 189 0.147
Baillargeon (2012)f Canada Athlete 17 17 NIC 14.8 8.8 0    0 No 174 0.151
Baillargeon (2012)e Canada Athlete 16 16 NIC 11 4.9 0    0 No 177 -0.199
7 1.339
28 1.044
7 1.658
28 1.352
Schatz & Sandel (2013)b USA Athlete 37 37 NIC   14 92   0 Yes 3 0.111
Schatz & Sandel (2013)a USA Athlete 81 81 NIC   33 92   0 Yes 3 0.631
6.2 0.443
26.2 0.374
79.5 0.134
0.0833 0.405
7 0.193
1 0.239
6 0.141
45 0.007
1 -0.023
6 0.015
50 0.063
Table 5.
Characteristics of Included Studies
Mixed
 10  Mixed No16.56  0
45.9   
21.05
No11.09 0
Miller (2003) USA Athlete 60 62 NIC
16.21
NIC 20.1  0 52.63
Pica (2007) USA Athlete 72 84 NIC
Mixed No
Bruce (2003) USA Athlete 19 19 68.42 Mixed No
16.3  54.16 0 0 0
No
Kontos (2016)b USA Athlete 
Broglio (2016) USA Athlete 24 21 NIC
   0
   0NIC 16.45  47
 4522 10* NIC 16.5 No
Kontos (2016)a USA Athlete 15 10*
USA Athlete 12 12 NIC Mixed
McCrea (2003) USA
Yes16.5    40 8.8Hammeke (2013)
20.04 14.78 0 43.2 0 0
Sample Information Demographic Information Injury Parameters
Athlete 94 56 NIC Mixed No
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Sample Country Population n MTBI n Control
Control 
Group
Age
Mean   
Education
%  
Female
% 
Previous 
MTBI
% 
LOC
% 
PTA
Psych 
Comorbidity 
PVTs TSI (days) d
Sim (2006) USA Athlete 14 14 NIC & PIB 15.6  0.4 40   Mixed No 6.3 0.924
McCrea (2002) USA Athlete 91 1189 NIC 17.52    15.6 16.48 Mixed No 0.0104 1.029
Stueland (2001) USA Athlete 14 12 NIC   0    0 Yes 4.5 0.394
Gardner (2012) Australia Athlete 46 41 NIC 24.2 13.89 0    Mixed Yes 1.935 0.371
Virji-Babul (2013) Canada Athlete 12 10 NIC 15.5  16.66    Mixed No 35.66 0.683
1 1.035
7 -0.054
1 1.137
7 0.911
Register-Mihalik (2013) USA Athlete 132 38 NIC & PIB 18.59 0 34.85    Mixed No 2.36 0.409
Sasaki (2014) Canada Athlete 16 18 NIC 21.68  38 38.23   Mixed No 95 0.009
1 0.479
5 0.382
10 0.467
Terry (2012) United States Athlete 20 20 NIC 20.3 14.3 0 100 22 44.4 0 No 588 0.363
Collie (2006)b Australia Athlete 36 42* NIC 23.3  0  19.4 36.1 Mixed No 3.5 -0.018
Collie (2006)a Australia Athlete 25 42* NIC 22.3  0  32 36 Mixed No 2.2 0.169
Gosselin (2007) Canada Athlete 10 11 NIC 24.3 14.7 30 100 20 40 0 No 132 0.413
Schatz (2005) USA Athlete 72 66 NIC 16.5 20.8 10.4  99  Mixed Yes 3 1.108
0.7954 0.527
8 0.169
15 0.073
45 0.035
1 0.542
5 0.345
1 0.267
8 0.011
15 -0.005
45 -0.08
Forbes (2016) US Athlete 105 105 NIC 15.9 10 100    Mixed No 813 0.016
Fischer (2016) USA GMR 11 12 NIC 33 14.09 27 36 54.5  Mixed No 0.246 1.061
Nash (2014) France GMR 89 70 OI 35.4  22.5  Mixed No 360 -0.185
Shores (2008) Australia GMR 79 86 OI 31.5 11.4 24    Mixed Yes 0.261 1.089
Mayer (2015) USA GMR 15 15 NIC 13.47 6.87 13.3  66.6  0 No 15.33 0.439
Barwood (2013) Australia GMR 16 16 NIC 38.25 12.875 37.5 0 87.5 37.5 0 No 348.75 -0.298
5.28 0.358
360 0.183
Mayer (2014) USA GMR 30 30 NIC 27.83 13 46.67    Mixed Yes 15 0.246
Saluja (2015) Canada GMR 15 15 NIC 15  53.3 20   Mixed No 39.3 0.456
Table 5 continued.
Sample Information Demographic Information Injury Parameters
Characteristics of Included Studies
GMR 49 49 NIC 34.9 12.6
NoChin (2016)
63.2 0   0 YesDall'Acqua (2017) Switzerland
11 16.3    MixedUSA Athlete 166 164 NIC & PIB 17.47
NoGuskiewicz (2001) US Athlete 36 36 NIC & PIB 19.5 13 31
17.46  
 19 31 Mixed
Nelson (2016) USA Athlete 165 166 NIC & PIB 16.4    Mixed Yes
 Macciocchi (1996) USA Athlete 183 48 NIC
 Mixed No
0 No  0  4.8
 Mixed NoField (2003)l USA Athlete 19 20 NIC 15.2
19.85  4 53
53   0
 Field (2003)m USA Athlete 35 18 NIC
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Sample Country Population n MTBI n Control
Control 
Group
Age
Mean   
Education
%  
Female
% 
Previous 
MTBI
% 
LOC
% 
PTA
Psych 
Comorbidity 
PVTs TSI (days) d
Raz (2011) USA GMR 28 18 NIC 35.6  32    0 No 558.9 0.895
Macciocchi (2013) USA GMR 53 64 OI 26.91 11.89 11.3 0   Mixed No 48 0.163
Xiong (2014) China GMR 25 25 NIC 32.5 12.84 36 0   Mixed No 32.07 0.538
Studer (2015) Germany GMR 36 27 OI 11  54.3 31.4 36.1 52.8 Mixed No 120 -0.05
Sheedy (2009) Australia GMR 100 100 OI 33.64 13.19 22    Mixed No 0.579 0.539
Goldstein (2001) USA GMR 18 14 NIC 62.3      Mixed No 24.99 0.365
Cicerone (1997) USA GMR 50 40 NIC 34.6 14.8     Mixed Yes 396 0.605
De Monte (2005) Australia GMR 112 32 OI 25.35 12.53 20.5 59   0 No 0.353 0.334
Borgaro (2003) USA GMR 14 14 NIC 46.1 11.8 30    Mixed No 15.6 1.207
Meyers (2004) USA GMR 57 32 CP 36.93 12.63 24.56    Mixed Yes 227.7 0.576
Hess (2003) USA GMR 33 33 OI 37.2 11 21    Mixed no 33.4 0.655
Shee (2016) USA GMR 91 86 NIC 33.7 14.3 938.5    Mixed No 39.5 0.208
Chen (2012) Taiwan GMR 20 18 NIC 36.6 15 50 0   0 No 16.9 0.211
Harman-Smith (2013) Australia GMR 84 95 OI 34.8 13.3 54    0 Yes 168.7 0.191
7 0.979
30 0.405
McNally (2013)d USA GMR 112 44.5* OI 11.83  33  0  Mixed No 10.5 -0.061
McNally (2013)c USA GMR 74 44.5* OI 12.15  23  100  Mixed No 10.5 -0.145
Subotic (2017)b Canada GMR 17 9* NIC 42.7 14.9 53 47   Mixed No 8.5 1.059
Subotic (2017)a Canada GMR 28 9* NIC 46.1 16.4 82 50   Mixed No 8.5 1.086
Bohen (1995)b Netherlands GMR 11 5.5* NIC 27.4 5.1 45.45    0 No 687 -0.434
Bohen (1995)a Netherlands GMR 11 5.5* NIC 27.2 4.6 45.45    0 No 678 0.456
1 -0.012
7 0.052
31.5 0.212
Lange (2015)b Canada GMR 52 18* OI 34.1 15.3 21.2 0 94.2 100 Mixed Yes 46.8 0.091
Lange (2015)a Canada GMR 20 18* OI 34.1 14.4 45 0 90 100 Mixed Yes 46.7 0.048
Acreman (2014) Canada GMR 41 39 CP 38.63 13.8 31.7    Mixed Yes 30 -0.818
Bergloff (1995) USA GMR 15 15 NIC 28 13.23 53.33    Mixed No 358.5 0.612
Sheedy (2006) Australia GMR 100 100 OI 33.62 13.22 31 44.8 72.4  Mixed No 0.725 0.497
Schmidt (2017) USA GMR 14 14 NIC 20.2 12.9     Mixed No 11 0.22
Bodzy (2011) USA GMR 62 82 NIC 10.83  46.66    0 No 2 0.167
Mayer (2011) USA GMR 27 26 NIC 27.15 13.22 57.7 0 0 0 0 Yes 11.32 0.166
De Monte (2005)h Australia GMR 50 18 OI 26.86 12.79 100    0 No 0.3246 1.039
De Monte (2005)i Australia GMR 14 8 OI 24.42 12.47 0    0 No 0.3342 0.569
4.4 0.389
93 0.25
Diwakar (2015) USA GMR 25 25 NIC 32.7 14.7 16  64 96 0 Yes 954 0.507
12.85 0.995
201 0.346
Table 5 continued.
Characteristics of Included Studies
Sample Information Demographic Information Injury Parameters
Van Beek (2015) Belgium GMR 20 20 NIC 0 No10.8  35 0   
0 NoNIC 26.7 13.14 35.14  81.08Padre (2009) Canada GMR 37 79 100
0 YesOI 13.5  43 19 25Sroufe (2010) USA GMR 28 45 29
0 No12.38 39NIC 23.22   Levin (1987) USA GMR 57 56  
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Sample Country Population n MTBI n Control
Control 
Group
Age
Mean   
Education
%  
Female
% 
Previous 
MTBI
% 
LOC
% 
PTA
Psych 
Comorbidity 
PVTs TSI (days) d
Keightley (2014) Canada GMR 15 15 NIC 14.47 0 53.33 20   0 No 41.13 0.422
Gulbrandsen (1984) Norway GMR 56 56 NIC 11.33  32.14 0   0 No 180 0.283
McKinlay (2002) New Zealand GMR 86 613 NIC 4.87  42.47 0   Mixed No 30 0.18
Leh (2017) Canada GMR 15 13 NIC 30.7 12.4 60 0 0 0 0 No 126 0.435
30 -0.017
120 0.166
30 -0.109
120 -0.041
Van Beer (2015) Belguim GMR 20 20 NIC 10.8  35 0   0 No 12.85 0.417
30 0.017
360 -0.073
Hattori (2009) USA Litigant 15 15 NIC 45 16 80    0 No 858 0.574
Lange (2014) Canada Litigant 43 36 OI 30.4 14.6 23.3 0 93 0 Mixed Yes 46.1 0.091
McAuley (2014) USA Litigant 73 65 OI 19.1 10.5 27.4  78.1  Mixed No 2.5208 2.18
+
Hattori (2009) USA Litigant 15 15 NIC 45 16 80    Mixed No 858 0.574
Leininger (1990)d USA Litigant 22 11.5* NIC 30.7 13.5 55  0  Mixed No 183 0.467
Leininger (1990)c USA Litigant 31 11.5* NIC 32.9 13.7 60  58.4  Mixed No 252 0.558
Curtis (2012) USA Litigant 71 133 CP 42.5 12.6 36.6  60.3 33.333 Mixed Yes 780 0.03
Richards (2000)g Canada Litigant 20 20 NIC 26.85 14.1 50 0 77  0 No 720 0.986
Richards (2000)j Canada Litigant 20 20 NIC 69.1 12.7 50 0 55  0 No 954 1.11
Zakzanis (2011) Canada Litigant 20 54 NIC 39 13.1 50    0 Yes 748.3 1.156
Mathias (2004) Australia Litigant 40 40 NIC 32.4 12.4 20  80  Mixed Yes 26.3 0.464
Raskin (1997)n USA Litigant 10 10 TC 41.8 14.2 100    1 No 427.2 0.293
Raskin (1997)o USA Litigant 10 10 NIC 40.4 13.2 100    Mixed No 746.7 0.843
7 0.259
90 0.139
1.62 0.027
14.6 -0.192
43.8 0.103
Haran (2016) United States Veteran 440 88 NIC 28.8  0    Mixed No 3.06 0.55
Roebuck-Spencer (2012)b USA Veteran 197 200* NIC 25.9  6.23  20.7 4.6 Mixed No 402 4.203
+
Roebuck-Spencer (2012)a USA Veteran 305 200* NIC 26  7.61  31.5 9.1 Mixed No 404 11.482+
Sorg (2014) USA Veteran 30 15 NIC 30.7 13.3 13 73 60 0 0 Yes 1080 0.353
Ivins (2015) USA Veteran 56 773 NIC 26.9  0  53.5 62.5 Mixed Yes 23 0.666
McCrea (2014) USA Veteran 63 554 NIC 26.65  0  54.7 29.4 Mixed No 1 1.613
Table 5 continued.
Characteristics of Included Studies
Sample Information Demographic Information Injury Parameters
29.11 Yes 39.4 35.1   MixedNelson (2017) USA Litigant 94 80 OI
OI 34.98 No13.58 26  92.5 96.7 Mixed
Dikmen (2017) USA Litigant 120 130
Ponsford (2011) Australia Litigant 90 80
 Mixed NoTC 28 12.4    
OI
No6 0 27.5 35 50 0
6 100 27.5 35 50Studer (2014)h Switzerland GMR 23 13 0 No
Studer (2014)i Switzerland GMR 17 25 OI 11.05
11.05
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Notes: LOC = Loss of Consciousness; PTA = Post-traumatic Amnesia; PVTs = Performance Validity Tests; TSI = Time Since Injury 
in days; NIC = Non-Injured Control; NIC & PIB = Non-Injured Control and Pre-Injury Baseline; TC = Trauma Control; OI = 
Orthopedic Injury; CP = Chronic Pain; GMR = General Medical Referral; *=outlying effect size prior to trimming; + = control group 
was split in half and distributed among both independent samples 
 
a = independent sample with PCS; b = independent sample without PCS; c = independent sample with LOC; d = independent sample 
with no LOC; e = independent sample with children; f = independent sample of high school/college students; g = independent sample 
of adults; h = independent sample of females; i = independent sample of males; j = independent sample of older adults; l = 
independent sample of high school students; m – independent sample of college students; n = independent sample of individuals who 
sustained traumas; o = independent sample of individuals who did not sustain trauma 
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Publication Bias. Given the lack of independence in studies with multiple 
outcome measures (i.e., memory, processing speed, executive functioning), all analyses 
assessing publication bias were conducted using the overall cognitive dysfunction 
outcome measure. A Fail-Safe N analysis across all time points revealed that 5,254 
missing studies with a null effect are needed to bring the observed effect size to a non-
significant value (i.e., p < .05). Visual inspection of a funnel plot reveals a general 
symmetry of observed effects across the overall observed effect (Figure 3), suggesting no 
evidence of publication bias. Similarly, a formal test of asymmetry, Egger’s regression 
intercept found a non-significant intercept (𝛽0 = 0.556, t(150) = 1.17, p = 0.24), which 
suggests no evidence of publication bias.  
Figure 3.  
Funnel Plot of Overall Effect Size  
 
 
Aim 1: Pair-Wise Meta-Analytic Findings 
 Cognitive Functioning Over Time. Table 6 shows the results of the random-
effects meta-analysis, which displays the observed effects size for each cognitive domain 
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stratified by time. This analysis does not control for potential effect modifiers (i.e., 
population, psychological comorbidity, PVTs). For this analysis, the time points are 
assumed to be independent of one another. While each study only contributes one study 
per time strata, there is an inherent violation of independence and perfect correlation (r = 
1.00) is assumed when comparing the effects between time strata (e.g., 24 hours vs > 90 
days). As such, the standard errors within a time point stratum may be erroneously small, 
resulting in an increase in potential Type I errors when estimating the effect size within 
each time strata. Conversely, assuming a perfect correlation across time points results in 
an inflation of the standard error when comparing between-time strata, resulting in an 
increase in potential Type II errors.  
 In general, medium to large effect sizes were evident in acute stages post-MTBI, 
which decreased over time. Contrary to expectation, effect sizes tended to increase again 
after 90 days post-MTBI. Consistent with Hypothesis 1, medium overall effect sizes were 
evident in the acute periods post-MTBI (≤24 hours, 1-8 days). In contrast to expectation, 
the overall effect size remained significant, even after 3 months. More detailed analyses 
across each cognitive domain are outlined below.  
 Overall Cognitive Dysfunction. The analogue-to-ANOVA failed to reach 
significance (Q Between(4) = 8.907, p = .063) suggesting there were no differences in 
observed effect sizes over time. Consistent with previous meta-analyses, a medium-to-
large effect size (d = .641) was observed when assessing overall cognitive functioning 
during the first 24 hours after sustaining an MTBI. A medium-small effect size is 
observed 1-8 days post-MTBI (d = .415) and small, but significant effect sizes is 
observed until 90 days post-MTBI (d range .271-.240). Contrary to the previous research, 
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Figure 4.  
Overall Cognitive Dysfunction Over Time  
 
 
 
 
Table 6
Cognitive Dysfunction Post-MTBI Stratified by Time  
k d 95% CI Q k d 95% CI Q k d 95% CI Q k d 95% CI Q k d 95% CI Q Q between
Orientation 11 0.887* 0.617-1.158 49.989* 2 0.252 -0.326-0.83 1.55 1 0.996 -0.09-2.082 0.00 3 0.143 -0.395-0.68 10.36* 2 0.584 -0.15-1.319 0.00 8.579
General Ability/IQ 5 1.296* 0.759-1.833 161.07* 7 0.232 -0.239-0.703 9.98 13 0.167 -0.185-0.52 25.683* 12 0.28 -0.092-0.651 25.68* 18 0.641* 0.327-0.956 23.17* 15.038*
Language/Achievement 1 0.201 -0.311-0.712 0.00 1 -1.071* -1.69 - -0.452 0.00 6 0.203 -0.036-0.442 7.20 4 0.121 -0.192-0.435 1.86 9 0.249* 0.053-0.445 14.63 16.188*
Attn/Working Memory 12 0.52* 0.33-0.711 30.3* 18 0.348* 0.188-0.508 29.8* 18 0.191* 0.016-0.366 44.76* 13 0.054 -0.144-0.251 12.53 28 0.27* 0.128-0.413 72.74* 12.838*
Processing Speed 14 0.605* 0.38-0.829 29.87* 30 0.472* 0.319-0.625 121.96* 18 0.203* 0-0.406 69.93* 13 0.26* 0.024-0.496 21.7* 30 0.274* 0.112-0.436 89.93* 10.667*
Executive Function 8 0.259 -0.015-0.533 15.1* 16 0.254* 0.073-0.434 30.54* 16 0.198 -0.005-0.401 68.56* 13 0.205 -0.02-0.431 23.69* 30 0.201* 0.046-0.356 67.32* 0.326
Immediate Memory 17 0.628* 0.405-0.851 128.85* 14 0.334* 0.085-0.584 75.89* 8 0.275 -0.061-0.61 5.52 10 0.3 -0.003-0.604 9.84 26 0.274* 0.076-0.472 45.22* 6.608
Delayed Memory 17 0.723* 0.504-0.942 137.94* 27 0.425* 0.25-0.6 127.45* 15 0.367* 0.12-0.615 36.2* 15 0.369* 0.131-0.607 28.08* 26 0.332* 0.138-0.526 33.89 8.289
Visuospatial Skills 4 0.379 -0.113-0.87 18.49* 6 0.238 -0.159-0.635 15.73* 8 0.312 -0.032-0.655 31.78* 10 0.345* 0.035-0.654 17.1* 0.245
Fine Motor Mvmt 2 0.786 0.291-1.281 0.64 2 0.459 0.056-0.862 1.23 3 0.078 -0.185-0.341 4.33 3 0.446 0.073-0.819 1.65 7 0.293 0.108-0.478 5.66 7.608
Overall 22 0.641* 0.432-0.85 116.55* 36 0.415* 0.251-0.578 139.592* 29 0.271* 0.083-0.459 90.407* 20 0.24* 0.015-0.464 22.00 45 0.391* 0.235-0.546 337.426* 8.907
Note . IQ = Intelligence Quotient; Attn = Attention; Mvmt = Movement
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified 
≤ 24 Hours 1-8 Days 9-30 Days 31-89 Days ≥ 90 Days
  62 
 
the effect size increases from small to medium-small after 90 days (d = .391). This 
finding likely reflects the fact that most of the studies with litigant and Veteran samples 
were assessed at this time point (see Population analyses). Significant between-study 
heterogeneity was observed for all time points except the 31-89 day time strata. 
Orientation. A large effect size (d = .887) in orientation was observed in the first 
24 hours post-MTBI. Effect sizes across the other time strata were non-significant, likely 
due to the small number of studies. Nevertheless, observed effect sizes in these time 
strata ranged from small to large (d range = .252-.996). The analogue-to-ANOVA failed 
to reach significance (Q Between(4) = 8.579, p = .073), suggesting no significant 
differences in observed effect sizes over time. Significant between-study heterogeneity 
was evident in the ≤ 24 hour and 31-89 day time strata.  
 General Ability and Intelligence. There were significant differences in observed 
effects across time points (Q Between(4) = 15.04, p = .005). A very large effect size was 
observed in the first 24-hours post-MTBI. Small, non-significant effect sizes (d range 
.280-.167) were observed in the 1-8 day, 9-30 day, and 31-89 day time strata, all of which 
were significantly smaller than the effect size observed ≤ 24 hours post-MTBI (all p’s < 
.05).  Mirroring the results of analysis of overall cognitive dysfunction, a non-significant 
increase in the effect size from small to medium-large was observed after 90 days (d = 
.641; Z = 1.46, p = .15). The effect size observed after 90 days remained significantly 
smaller than the initial effect size observed at 24 hours (Z = 2.060, p = .04). Significant 
between-study heterogeneity was observed in all time strata except the 1-8 day time 
strata.  
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Language and Academic Achievement. The analogue-to-ANOVA was 
significant (Q Between(4) = 16.188, p < .01) suggesting differences in observed effect 
sizes over time. A small, non-significant effect size was observed in the first 24 hours, 
post-MTBI (d = .201). After 1-8 days, the effect size significantly decreased from small 
to a very large, negative effect size (d = -1.07; Z = 3.10, p < .001). Notably, this observed 
effect was derived from a single study (Moser et al., 2005) and this effect size was 
identified as an outlier and trimmed to its current value of -1.07; thus, this is unlikely to 
be an accurate reflection of the true population effect size at this time point. Small, non-
significant effect sizes were observed in the 9-30 day and 31-89 day time strata. 
Mirroring the previous analyses, a non-significant increase in effect size (Z = .676, p = 
.50) was observed after 90 days. After 90 days, a small, but significant effect size was 
observed (d = .249), This effect size did not differ from the non-significant effect size 
observed the initial 24 hours post-MTBI (Z = .17, p = .86). No significant between-study 
heterogeneity was observed.  
 Attention and Working Memory. The analogue-to-ANOVA was significant (Q 
Between(4) = 12.838, p = .012), suggesting differences in observed effect sizes across 
time strata. A medium effect size was observed in the first 24 hours post-MTBI (d = 
.520). A non-significant decrease to a medium-small effect size (d = .348) was observed 
in the 1-8 day time strata. A small, but significant, effect size was observed after 9-30 
days (d = .191) and a near-zero effect size was observed after 31-89 days (d = .054). Both 
of these observed effect sizes were significantly smaller than the effect size observed in 
the first 24 hours post-MTBI (all p’s < .05). A non-significant increase in observed effect 
size was observed after 90 days (d = .270, Z = 1.74, p = .08). The small effect size 
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observed after 90 days was significantly smaller than the medium effect size observed in 
the first 24 hours post-MTBI (Z = 2.06, p = .04). Significant between-study heterogeneity 
was observed in all time strata except the 31-89 day stratum.   
 Processing Speed. The analogue-to-ANOVA was significant (Q Between(4) = 
10.667, p .031), suggesting differences in observed effect sizes across time. A medium-
large effect size was observed in the first 24 hours post-MTBI (d = .605). A non-
significant decrease to a medium effect size (d = .472) was observed after 1-8 days (Z = 
.956, p = .33). A significant decrease to a small effect size was observed in the 9-30 day 
time strata (d = .203; Z = 2.07, p = .0381). Small, but significant, effect sizes were 
observed across the remaining time strata (d = .260 and .274). Significant between-study 
heterogeneity was observed in all time points.  
 Executive Functioning. The analogue-to-ANOVA was not significant (Q 
Between(4) = .326, p = .99), suggesting there were no differences in observed effect sizes 
over time. In the first 24 hours post-MTBI, a small, non-significant effect size was 
observed (d = .259). Small effect sizes were observed across the remaining time strata; 
however, only the effect sizes from the 1-8 day stratum and > 90 day stratum reach 
statistical significance (d = .245 and .201, respectively). Significant between-study 
heterogeneity was observed in all time strata.  
 Immediate Memory. The analogue-to-ANOVA failed to reach statistical 
significance (Q Between(4) = 6.61, p = .158). In the first 24 hours post-MTBI, a medium-
large effect size was observed (d = .605). This was reduced to a medium-small effect size 
after 1-8 days (d = .334). Non-significant, medium-small effect sizes were observed in 
the 9-30 day and 31-89 day strata (d = .275 and .300, respectively). However, a medium-
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small effect size after 90 days did reach statistical significance (d = .274). Significant 
between-study heterogeneity was observed in all time strata except the 9-30 day and 31-
89 day time strata.  
 Delayed Memory. The analogue-to-ANOVA failed to reach statistical 
significance (Q Between (4) = 8.289, p = .082). In the first 24 hours post-MTBI a 
medium-large effect size was observed (d = .723). Significant, medium-large effect sizes 
were observed across the remaining time strata (d range = .332-.425). Significant 
between-study heterogeneity was evident in all strata except the > 90 day time strata.  
 Visuospatial Skills.  The analogue-to-ANOVA failed to reach statistical 
significance (Q Between (4) = .245, p = .970), suggesting no differences in observed 
effect sizes across time points. A non-significant, medium-small effect size (d = .375) 
was observed 1-8 days post-MTBI. Non-significant, small (d = .238) and medium-small 
(d = .312) were observed in the 9-30 and 31-89 day time strata. After 90 days, a 
significant, medium-small effect size was observed (d = .345). Between-study 
heterogeneity was evident across all time strata.  
 Fine Motor Movement. The analogue-to-ANOVA failed to reach statistical 
significance (Q Between(4) = 7.608, p = .107). A medium-large effect size was observed 
in the first 24 hours post-MTBI; however, this effect failed to reach significance, likely 
due to the small number of included studies. Similarly, the observed effect sizes for the 
remaining time strata failed to reach statistical significance (d range = .078 - .459).  
 Population. Random effects Analogue-to-ANOVA was conducted to examine 
differences in overall cognitive functioning across different populations (See Table 7). In 
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Figure 5.  
Line Graph of Overall Cognitive Dysfunction Over Time by Population  
 
 
 
Table 7
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Population 
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
Athletes 13 0.575* .357-.792 49.64* 75.82 27 0.366* .192-.540 65.76* 60.46 7 0.271 -.044-.585 25.74* 76.69 9 0.078 -.060-.216 13.02 38.56 13 0.125 -0.099-0.35 3.02 0.00
GMR 8 0.594* .305-.883 18.96* 63.08 5 0.357 -0.038-0.752 5.22 23.43 18 0.247* .033-.461 46.2* 63.21 9 .283* .110-.456 4.92 0 18 0.262* 0.071-0.453 22.61 24.82
Litigants 3 0.777* .291-1.264 57.79* 96.54 3 0.093 -.358-.544 4.39 54.45 2 0.097 -.230-.424 0 0 11 0.437* 0.193-0.68 29.81* 66.46
Veterans 1 1.613* .920-2.306 - - 1 0.55 -0.231-1.33 - - 1 0.667 -.065-1.397 - - 3 1.859* 1.425-2.292 35.1* 94.30
Q Between 8.022* 2.632 1.724 3.426 51.292*
Notes. GMR = General Medical Referral 
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified 
≤ 24 Hours 1-8 Days 9-30 Days 31-89 Days ≥ 90 Days
-0.5
-0.25
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2
2.25
2.5
≤ 24 hr 1-8 Days 9-30 Days 31-89 Days ≥90 Days
Athlete GMR Litigant Veteran
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contrast to the analyses reported above, there is no violation of independence as the 
between-study analyses did not examine the effects of time, but rather population 
membership.  
 In general, differences in sample population were found in the first 24-hours 
post-MTBI and after 90 days, with samples that included Veterans having the largest 
effect sizes. Samples that included athletes tended to have smaller effect sizes than 
samples with general medical referrals (GMR) in the post-acute periods after the injury; 
though these differences were not significant. Samples that included Veterans and 
individuals involved in litigation continued to have medium to large effect sizes 90 days 
after injury. Hypothesis 2A, that differences across populations would be evident, was 
partially fulfilled. More detailed analyses regarding the overall effect of sustaining an 
MTBI across various populations are provided below.  
 Population: 24 Hours or Less Post-Injury. Medium effect sizes were observed 
for the athlete and GMR populations (d = .575 and .594, respectively). A very large effect 
size was observed for Veteran populations (d = 1.613), though this estimate was derived 
from a single study (French, McCrea, & Baggett, 2008). The analogue-to-ANOVA (Q 
Between (2) = 8.022, p = .018) was significant suggesting differences in in effect sizes 
across populations. The observed effect sizes for the GMR and athlete populations were 
similar in magnitude (Z = .104, p = .92). However, the effect size for the Veteran 
populations was significantly larger than the athlete and GRM populations (Z =2.80 and 
2.66, all p’s < .05). Significant between-study heterogeneity was observed for the athlete 
and GMR populations, with 63-75% of the variability unexplained. Given there was a 
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single study across the Veteran population, metrics of between-study heterogeneity 
cannot be calculated.   
 Population: 1-8 Days Post-Injury. The analogue-to-ANOVA failed to reach 
significance (Q Between(3) = 2.63, p = .45), suggesting no differences in observed effect 
sizes across populations. After 1-8 days, a medium-to-large effect size was observed for 
studies that include individuals involved in litigation (d = .777). A significant medium-
small effect size was observed for studies that included athletes (d = .366), and a non-
significant medium-small effect size was observed for GMR populations (d = .357). A 
medium, non-significant effect size was observed in the Veteran population, though only 
one study contributed to this effect. Significant between-study heterogeneity was 
observed the athlete and litigant populations, with 60-97% of the variability unexplained.  
 Population: 9-30 Days Post-Injury.  The analogue-to-ANOVA failed to reach 
significance (Q Between(3) = 2.632, p = .452), suggesting no differences in observed 
effect sizes across populations 9-30 days post-MTBI. A small, significant effect size was 
observed for the GMR population (d = .247), while studies that included athletes also had 
a small effect that failed to reach significance (d = .271). A non-significant, medium-
large effect size was observed in Veteran population (d = .667), though only a single 
study contributed to this estimate. Finally, a near-zero effect size was observed for 
studies that included individuals involved in litigation (d = .093). Significant between-
study heterogeneity was evident for studies involving athletes and GRM with 63-80% of 
the variability left unexplained.  
 Population: 31-89 Days Post-Injury. The analogue-to-ANOVA failed to reach 
significance (Q Between (2) = 3.426, p = 0.18), suggesting no differences in observed 
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effect sizes across populations after 31-89 days post-MTBI. A near-zero effect size was 
observed for studies involving athletes (d = .078) and individuals involved in litigation (d 
= .097). A small, significant effect size was observed for studies involving GMR (d = 
.283). Significant between study-heterogeneity was evident in studies involving athletes, 
with 39% of the variance between studies left unexplained.  
 Population: 90 Days or More Post-Injury. The analogue-to-ANOVA was 
significant (Q Between(3) = 51.292, p < .001), suggesting differences in observed effect 
sizes across populations 90 days after injury. A near-zero effect size was observed for 
studies that involved athletes (d = .125). A small, significant effect size was observed for 
studies involving GRM (d = .262). A significant, medium-small effect size was observed 
for studies that included individuals involved in litigation (d = .437). A very large effect 
size was observed for studies involving Veterans (d = 1.895), which was significantly 
larger than the observed effect sizes across the other populations (all p’s < .05). 
Significant between-study heterogeneity was observed for studies involving litigants and 
Veterans with 66-94% of the variability left unexplained.  
 Age. A random-effects meta-analysis was conducted to compare the overall 
cognitive sequalae of sustaining an MTBI across different age groups and time points 
(See Table 7). In general, consistent with Hypothesis 2B, there were no significant 
differences in the observed effect sizes across different age groups. While the differences 
were not significant, samples that included older adults tended to have the largest effect 
sizes, followed by samples that included adults. Drawing conclusions about these 
apparent differences were difficult given the small number of studies in certain groups.
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Figure 6.  
Line Graph of Overall Cognitive Dysfunction Post-MTBI Over Time by Age 
 
 
 
 
Table 8
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Age 
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
Children 1 -0.01 -.908-.884 - - 1 0.052 -.872-.976 - - 6 0.235 -.120-.590 11.04 54.72 2 0.297 -.179-.774 0.19 0.00 4 0.075 -0.648-0.798 2.07 0.00
HS/College 13 0.575* .326-.824 49.64* 75.82 26 0.454* .243-.565 126.58* 80.25 10 0.214 -.068-.496 26.52* 66.07 10 0.108 -.040-.256 14.09 36.12 11 0.119 -0.301-0.538 1.68 0.00
Adults 8 0.839* .516-1.161 44.57* 84.30 9 .326* .044-.609 11.86 32.53 12 0.299* .041-.558 50.35* 78.15 8 0.226* -.040-.256 5.30 0.00 29 0.514* 0.254-0.774 302.53* 90.74
Older Adults 1 0.365 -.636-1.37 - - 1 1.110 -0.311-2.531 - -
Q Between 3.757 1.155 0.254 1.347 4.201
Notes. HS/College = High School and College
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified 
≤ 24 Hours 1-8 Days 9-30 Days 31-89 Days ≥ 90 Days
-1.5
-1
-0.5
0
0.5
1
1.5
2
2.5
3
≤ 24 hr 1-8 Days 9-30 Days 31-89 Days ≥90 Days
Children HS/College Adults Older Adults
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 More detailed analyses regarding the age and the overall effects of sustaining an MTBI 
are provided below. 
Age: 24 Hours or Less Post-Injury. The analogue-to-ANOVA failed to reach 
significance (Q Between(2) = 3.76, p = .15), suggesting no differences in overall effect 
size across age groups in the first 24 hours post-MTBI. A near-zero effect size was 
observed for the single study that included children (d = -.01). A significant, medium 
effect size was observed for studies that included samples with high school and college-
aged students (d = .575). A significant, large effect size was observed with studies that 
included adults. Significant between-study heterogeneity was observed for studies that 
included high school and college-aged students as well as adults, with 76-84% of the 
variability left unexplained.  
 Age: 1-8 Days Post-Injury. The analogue-to-ANOVA failed to reach significance 
(Q Between(2) = 1.155, p = .561), suggesting no differences in overall effect size across 
age groups in the 1-8 days post-MTBI. A near-zero effect size was observed for the 
single study that included a sample of children (d = .052). Significant medium-small 
effect sizes were observed for studies that included high school and college-aged students 
(d = .454) and adults (d = .326). Significant between-study variability was observed for 
studies that included high school and college-aged students, with 80% of the variability 
left unexplained.  
 Age: 9-30 Days Post-Injury. The analogue-to-ANOVA failed to reach 
significance (Q Between(3) = 0.25, p = .0.97), suggesting no differences in overall effect 
size across age groups in the 9-30 days post-injury. Small, but non-significant effect sizes 
were observed in studies that included children (d = .235) and high school and college-
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aged students (d = .214). A significant, medium-small effect size was observed in studies 
that included adults (d = .299). And a non-significant, medium-small effect size was 
observed in the single study that included older adults (d = .365). Significant between-
study heterogeneity in studies that included high school and college-aged students and 
adults with 66-78% of variance in observed effect sizes within these groups left 
unexplained.  
 Age: 31-89 Days Post-Injury. The analogue-to-ANOVA failed to reach 
significance (Q Between(2) = 1.347, p = 0.51), suggesting no differences in overall effect 
size across age groups in the 31-89 days post-injury. Small, non-significant effect sizes 
were observed for samples that included children (d = .297) and high school and college-
aged students (d = .108). A small, but significant effect size was observed for studies that 
included adults (d = .226). Between-study heterogeneity was not found across any of the 
age groups.  
 Age: 90 Days or More Post-Injury. The analogue-to-ANOVA failed to reach 
significance (Q Between(3) = 4.201, p = .241), suggesting no differences in overall effect 
size across age groups 90 days or more post-MTBI. A near-zero effect size and small, 
non-significant effect size was observed for studies that included children and high-
school and college-aged students, respectively (d = .075 and .119). A medium effect size 
was observed in samples that included adults (d = .514) and a very large, but non-
significant effect size was observed in the single study that included older adults (d = 
1.110). Significant between-study heterogeneity was evident in studies that included 
adults, with 91% of the variance in observed effect sizes within these groups left 
unexplained.  
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Psychological Comorbidity. A random-effects analogue-to-ANOVA meta-
analysis was conducted to examine the presence of psychological comorbidity on the 
overall cognitive effects of sustaining an MTBI (see Table 9). Contrary to Hypothesis 
2C, studies that included participants without comorbid mental health disorders did not 
have smaller effect sizes than studies where mental health disorders may have been 
present. These unexpected findings may be the result of the methodological decisions 
regarding these data. That is, most studies were coded as “mixed” if the authors did not 
specifically note that subjects were included/excluded for having mental health disorders 
or if the composition fell anywhere between 1 and 99%. Additional details of the 
analyses are presented below.   
 Psychological Comorbidity: 24 Hours or Less Post-Injury. The analogue-to-
ANOVA failed to reach statistical significance (Q Between(1) = 1.239, p = .266), 
suggesting there were no differences in the observed effect sizes between individuals 
with and without psychological comorbidities in the first 24 hours post-MTBI. A 
medium-small effect size was observed for studies where participants did not have 
psychological comorbidities (d = .428) and a medium-large effect size was observed in 
studies where psychological comorbidities were not excluded (d = .701). Significant 
between-study heterogeneity was evident in studies where participants had psychological 
comorbidities, with 84.34% of the variance in observed effect sizes within these groups 
left unexplained. 
 Psychological Comorbidity: 1-8 Days Post-Injury. The analogue-to-ANOVA 
failed to reach statistical significance (Q Between(1) = .362, p = .547), suggesting there 
were no differences in the observed effect sizes between individuals with and without 
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Figure 7.  
Line Graph of Overall Cognitive Dysfunction Post-MTBI Over Time by Psychological Comorbidity  
 
 
 
 
 
 
 
Table 9
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Psychological Comorbidity 
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
0% 5 0.428* 0.002-0.854 5.44 26.51 12 0.474* 0.215-0.734 22.28* 50.64 10 0.446* 0.162-0.729 14.90 39.58 4 0.534* 0.204-0.864 2.50 0.00 25 0.325* 0.033-0.618 28.69 16.34
Mixed 17 0.701* 0.476-0.927 102.19* 84.34 24 0.378* 0.202-0.554 116.24* 80.21 19 0.167 -0.013-0.348 66.7* 73.01 16 0.104* 0.002-0.206 13.55 0.00 19 0.476* 0.156-0.796 305.61* 94.11
100% 1 0.293 -1.277-1.863 - -
Q Between 1.239 0.362 2.639 5.954* 0.481
Notes. Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified 
≤ 24 Hours 1-8 Days 9-30 Days 31-89 Days ≥ 90 Days
-0.25
0
0.25
0.5
0.75
1
≤ 24 hr 1-8 Days 9-30 Days 31-89 Days ≥90 Days
0% Mixed 100%
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psychological comorbidities 1-8 days post-MTBI. A medium-small effect size was 
observed in studies where subjects had no psychological comorbidities (d = .474) and 
studies where psychological comorbidities were not excluded (d = .378). For both groups, 
significant between-study heterogeneity was evident, leaving 50-80% of the variability in 
observed effect sizes within these groups left unexplained.  
 Psychological Comorbidity: 9-30 Days Post-Injury. The analogue-to-ANOVA 
failed to reach statistical significance (Q Between(1) = 2.64, p = .100), suggesting there 
were no differences in the observed effect sizes between individuals with and without 
psychological comorbidities 9-30 days post-MTBI. While the effect sizes did not 
significantly differ, there was an unexpected finding in which a significant small-medium 
effect size was observed in studies where participants did not have psychological 
comorbidities (d = .446); whereas, a small, non-significant effect size was observed for 
studies where psychological comorbidity may have been evident (d = .167).  Significant 
between-study heterogeneity was evident for studies with mixed psychological 
comorbidities, leaving 73% of the variability in observed effect sizes within this group 
left unexplained.  
 Psychological Comorbidity: 31-89 Days Post-Injury. The analogue-to-ANOVA 
did reach statistical significance (Q Between(1) = 5.954, p = .015), suggesting there were 
differences in the observed effect sizes between individuals with and without 
psychological comorbidities 31-89 days post-MTBI. Contrary to expectation, the samples 
with no psychological comorbidities yielded a significantly larger effect size (d = .534) 
than studies that included participants with psychological comorbidities (d =.104). 
Significant between-study heterogeneity was not evident.  
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 Psychological Comorbidity: 90 Days or More Post-Injury. The analogue-to-
ANOVA failed to reach statistical significance (Q Between(2) = .481, p = .786, 
suggesting there were no differences in the observed effect sizes between individuals 
with and without psychological comorbidities after 90 days post-MTBI. Medium-large 
effect sizes were observed for studies where participants did not have psychological 
comorbidities (d = .325) and studies where psychological comorbidities may have been 
evident (d = .476). A small, non-significant effect size was observed for the single study 
where all study participants had a comorbid mental health disorder (d = .293). Significant 
between-study heterogeneity was evident for studies where psychological comorbidities 
were not excluded, leaving 94% of the variability in observed effect sizes within this 
group left unexplained.  
Performance Validity Testing. A random-effects analogue-to-ANOVA meta-
analysis was conducted to examine if the utilization of PVTs on the overall cognitive 
effects of sustaining an MTBI (see Table 10). In general, the results showed no 
significant differences in observed effect sizes between groups, contrary to Hypothesis 
2D. While the differences did not reach statistical significance, studies that utilized PVTs 
tended to have smaller effect sizes than studies that did not screen for suboptimal effort 
with PVTs. Further details of the analyses are outlined below.   
 PVT: 24 Hours or Less Post-Injury. The analogue-to-ANOVA failed to reach 
statistical significance (Q Between(1) = .347, p = .556, suggesting there were no 
differences in the observed effect sizes between studies that did and did not utilize PVTs 
in the first 24 hours post-MTBI. A medium effect size was observed for studies that 
utilized PVTs (d = .510) and a medium-large effect size was observed for studies that did 
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Figure 8.  
Line Graph of Overall Cognitive Dysfunction Post-MTBI Over Time by Performance Validity Testing 
 
 
 
 
 
 
 
Table 10
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Performance Validity Testing
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
k d 95% CI Q I
2
PVTs Not 
Used 18 0.671* 0.441-0.902 100.27* 83.05 27 0.423* 0.252-0.593 113.12* 77.01 22 0.313* 0.123-0.504 55.77* 62.35 13 0.213* 0.076-0.349 20.79 42.29 37 0.382* 0.143-0.62 321.47* 88.80
PVTs Used 4 0.51* 0.028-0.993 15.8* 81.01 9 0.369* 0.086-0.653 25.95* 69.18 7 0.105 -0.198-0.409 34.58* 82.65 7 0.078 -0.115-0.271 0.34 0.00 8 0.434 -0.052-0.92 14.41* 51.43
Q Between 0.347 0.1 1.299 1.252 0.036
Notes.  PVT = Performance Validity Test
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified
≤ 24 Hours 1-8 Days 9-30 Days 31-89 Days ≥ 90 Days
-0.500
-0.250
0.000
0.250
0.500
0.750
1.000
1.250
≤ 24 hr 1-8 Days 9-30 Days 31-89 Days ≥90 Days
PVT- PVT+
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not utilize PVTs (d = .671). Significant between-study heterogeneity was evident, with 
81-83% of the variability in observed effect sizes within each group left unexplained.  
PVT: 1-8 Days Post-Injury. The analogue-to-ANOVA failed to reach statistical 
significance (Q Between(1) = 0.100, p = .752), suggesting there were no differences in 
the observed effect sizes between studies that did and did not utilize PVTs 1-8 days post-
MTBI. Small-medium effect sizes were observed for studies that did utilize PVTs (d = 
.369) and for studies that did not utilize PVTs (d = .423). Significant between-study 
heterogeneity was evident for both groups, leaving 68-77% of the variability in observed 
effect sizes within each group left unexplained.  
 PVT: 9-30 Days Post-Injury. The analogue-to-ANOVA failed to reach statistical 
significance (Q Between(1) = 1.30, p = 0.25), suggesting there were no differences in the 
observed effect sizes between studies that did and did not utilize PVTs 9-30 days post-
MTBI. A small-medium effect size was observed for studies that did not utilize PVTs (d 
= .313), whereas a small, non-significant effect size was observed for studies that utilized 
PVTs (d = .105). Significant between-study heterogeneity was observed for both groups, 
with 62-85% of the variability in observed effect sizes within each group left 
unexplained.   
PVT: 31-89 Days Post-Injury. The analogue-to-ANOVA failed to reach 
statistical significance (Q Between(1) = 1.252, p = 0.263), suggesting there were no 
differences in the observed effect sizes between studies that did and did not utilize PVTs 
31-89 days post-MTBI. A small, significant effect size was observed for studies that did 
not utilize PVTs (d = .213), whereas a non-significant, near-zero effect size was observed 
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for studies that utilized PVTs (d = .078). Significant between-study heterogeneity was not 
observed for either group.  
 PVT: 90 Days or More Post-Injury. The analogue-to-ANOVA failed to reach 
statistical significance (Q Between(1) = .036,  p = 0.85), suggesting there were no 
differences in the observed effect sizes between studies that did and did not utilize PVTs 
90 days after injury. A significant small-medium effect size was observed for studies that 
did not utilize PVTs (d = .382), whereas a non-significant, small-medium effect size was 
observed for studies that utilized PVTs (d = .434). This seemingly incongruous findings 
that the larger effect size (PVTs used) failed to reach significance is likely an issue of 
power as only 8 studies were included; whereas, 37 studies were included in the former 
analysis. Significant between-study heterogeneity was not observed for both groups, with 
51-89% of the variability in observed effect sizes within each group left unexplained.  
Aim 1 Summary. When considering a heterogenous population and not 
stratifying based on moderator variables, medium to large effect sizes were observed 
across all cognitive domains in the acute stages of MTBI recovery. The effect size 
decreased over the first 90 days. Contrary to expectation, the overall effect size appeared 
to increase 90 days after injury. Subsequent analyses suggested this was likely driven by 
the medium and very large effect sizes observed in studies during this time strata that 
included individuals involved in litigation and Veterans, respectively. Across most time 
strata, significant differences were not observed across age categories, studies that 
utilized PVTs, and the composition of psychological comorbidities.   
Hypothesis 1: Consistent with the previous literature, a medium overall effect is expected 
in the acute period post-MTBI that will fail to reach significance after three months. This 
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hypothesis was partially supported. A medium overall effect was observed in the acute 
stages, but it remained significant and increased after three months.  
Hypothesis 2: It is expected that (a) effect sizes will differ across the different 
“populations;” (b) effect sizes will not differ for the different age groups (c) effect sizes 
will differ for individuals with psychological comorbidities (d) effect sizes will differ for 
studies where effort testing is implemented. This hypothesis was partially upheld. 
Between-group differences were observed across the different populations (a) and effect 
sizes did not generally differ across age groups (b). Contrary to expectation, neither 
psychological comorbidities (c) nor utilization of PVTs (d) resulted in differences in 
observed effect sizes.  
Hypothesis 3: Despite stratifying by these different effect modifiers and performing 
multiple sub-group analyses, it is hypothesized that between-study heterogeneity will still 
exist. This hypothesis was upheld. Across most comparisons, significant between-study 
heterogeneity was evident, with I2 values as high as 94%. This suggests that stratifying by 
an effect modifier across different time points is not sufficient to explain the variability 
observed across the heterogenous population.  
Aim 2: Meta-Regression Analyses 
A random-effects meta-regression was conducted utilizing the furthest, most non-
acute time point from each study, yielding 152 unique observations. Variables of interest 
were first entered into the regression equation alone. Then, all significant variables were 
entered into a single regression model (See Table 11; Etnier et al., 2006; Lee et al., 2012).
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Table 11
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction After MTBI
B SE t B SE t B SE t B SE t B SE t B SE t B SE t
Intercept 0.395 0.044 9.06*** 0.393 0.062 6.30*** 0.222 0.117 1.89 0.287 0.087 3.28*** 0.062 0.046 0.183 0.338 0.056 6.01*** 0.437 0.244 1.79
MTSI 0 0 0.67 0 0 0.23
MTSI
2
0 0 0.06
Age 0.007 0.005 1.55
PVT 0.143 0.101 1.42
Psych d 0.47 0.052 9.01*** 0.457 0.054 8.51***
Population
     GMR -0.012 0.085 -0.14 -0.414 0.247 -1.68
     Litigant 0.08 0.121 0.66 -0.303 0.251 -1.21
     Veteran 0.976 0.185 5.26 -0.626 0.403 -1.55
k
Model F
Q
I
2
R
2
 Analog
Notes.  MTSI = Mean Time Since Injury; PVT = Performance Validity Testing; GMR = General Medical Referall; Psych d = The effect size of psychological distress 
For PVT, the reference group is studies that utilized PVTs to screen for adequate effort; For Population, the reference group were studies that included Athletes 
* = p  < .05; ** = p < .01; *** = p < .001
Model 1 Model 2
152
0.04
805.29***
0.010.00
152
0.22
803.19***
81.45%
0.00
81.37%
Model 3
144
2.39
771.05***
81.58%
0.99
Model 4
152
2.01
803.23***
81.33%
0.01
Model 5
36
81.18***
24.1
0.01%
152
9.76***
592.06***
81.28%
F(3,148) = 9.76*** F(3, 31) = 1.55
Model 7
36
21.46***
19.45
0.01%
0.990.30
Model 6
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Figures 9-11 
Scatterplots of Moderator Variables and Overall Cognitive Dysfunction  
 
 
 
 
 
 
 
 
 
 
Note. The size of the circles in the plot represent the relative weight each study has on the overall observed effect size
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Time Since Injury. The average amount of time that had passed since sustaining 
an MTBI was entered into the regression equation as a continuous variable (Models1and 
2). For the linear and non-linear models, the data were centered about the mean of 138.09 
days. Contrary to expectation, neither the linear nor quadratic (i.e., Time2) equation for 
mean time since injury was a significant predictor of the overall effect size (F(1,150) = 
0.44, p = .51; F(1,150) = .022, p = .80). This unexpected finding is likely due to 
increasing observed effect size after 90 days that was observed in analysis from Aim 1 
(see Figure 4).  For both models, nearly 0% of the between-study variability is explained 
by the models (R2 Analog = 0.01 for both models). Given that time since injury is not a 
significant predictor, it was not entered into subsequent regression analyses as proposed.  
Age. The average age of the study samples was entered into the regression 
equation as a continuous variable (Model 3). Consistent with Aim 1 analyses, this model 
failed to reach statistical significance (F(1,142) = 2.39, p = .12) and again almost no 
between-study variability explained by the model (R2 Analog = 0.01).  
PVT. Performance validity testing was entered into the regression equation as a 
categorical variable (Model 4). Studies that utilized performance validity testing to 
exclude subjects with sub-optimal effort was used as the reference group. Consistent with 
Aim 1 analyses, this model failed to reach statistical significance (F(1,150) = 2.01, p = 
.16). Almost no between-study variance was explained by the model (R2 Analog = 0.01). 
Psychological Functioning. A regression model using the composition of 
psychological comorbidities as a categorical variable (0%, mixed, 100%) was first 
entered into a meta-regression (not modelled). Consistent with the results of Aim 1, the 
model failed to reach statistical significance (F(2,149) = .06, p = .9448).  
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Next, the overall effect size of self-reported psychological functioning across all 
domains (e.g., depression, anxiety, SUD) was entered into the regression equation as a 
continuous variable (Model 5; Figure 5). There was one observed outlier that was > 3 
standard deviations above the average of all effect sizes (d = 13.289). It was trimmed to 
the next nearest group of effect sizes (d = 4.05). This model reached statistical 
significance (F(1,34) = 81.18, p < .001). Based on this model, studies where the 
differences in psychological functioning between the MTBI and control group was 
almost non-existent (Psych d = 0.00) or the differences were small (Psych d = 0.20) a 
small-medium effect size was predicted (d = .338 and .432, respectively). When the 
effect size in self-reported psychological functioning between MTBI and control groups 
is medium (Psych d = .50), then a medium effect size for cognitive functioning is 
predicted (d = .573). When the differences in psychological wellbeing between the two 
groups are large (Psych d = .80), the predicted effect size is medium-large (d = .714). 
This model explains nearly 100% of the between-study variance (R2 Analog = .99). 
While this model was extremely predictive, it is worth noting that this analysis included a 
minority (k = 36) of the extracted studies.  
 Population. Population membership (i.e., Athlete, Veteran, GMR, Litigant), was 
entered into the meta-regression as a categorical variable with studies that included 
athletes as the reference group (Model 6; Figure 6). Athletes were selected as the 
reference group based on a priori knowledge that athletes tend to recovery faster than 
other populations after an MTBI (Belanger, Curtiss, et al., 2005; Belanger & 
Vanderploeg, 2005). The overall model was significant (F(3,148) = 9.76. p < .001). 
However, of the sub-groups, only studies that included Veterans was a significant 
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predictor (t(148) = 5.26, p < .001), suggesting studies that included individuals involved 
in litigation and GRM did not differ in observed effect size from athletes. Based on the 
model, a small-medium overall cognitive effect size (d = .338) is observed for athletes 
after sustaining an MTBI, whereas a very large effect size (d = 1.314) is observed for 
Veterans who sustain an MTBI. This model explains 30% of the between-study variance 
(R2 Analog = .30). A Time x Population interaction, however, failed to reach significance 
(F(4, 147) = 1.19, p = 0.31).  
 Combined Models. A regression model with self-reported psychological 
functioning (Psych d) and population membership were simultaneously entered into the 
regression equation (Model 7). The overall model was significant (F(4,31) = 21.46, p < 
.001) with nearly all of the between-study variance explained by the model (R2 Analog = 
.99). The observed differences in psychological well-being between MTBI and control 
groups (Psych d) was a significant predictor (t(31) = 8.51, p < .001), whereas population 
membership was not a significant predictor (F(3,31) = 1.55, p .221). Similar to Model 5, 
no differences in self-reported psychological functioning between the MTBI and control 
groups (Psych d = 0.00) resulted in a small-medium overall cognitive effect size (d = 
.437). Small (Psych d = .20) and medium (Psych d = .50) differences in psychological 
functioning resulted in medium predicted effect size of overall cognitive functioning (d = 
.528 and .665, respectively). Large differences in psychological well-being (Psych d = 
.80) resulted in a large predicted effect size of overall cognitive functioning (d = .802).  
 Aim 2 Summary. A meta-regression to control for potential between-study 
heterogeneity and quantify the effect of covariates on the overall neuropsychological 
functioning post-MTBI was conducted. Surprisingly, the mean time since sustaining an 
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MTBI was not a significant predictor; though this is likely due the increase in observed 
effect sizes in the chronic periods (> 90 days) post-MTBI. Consistent with Aim 1 
analyses, the age of the study sample and the utilization of PVTs were not significant 
predictors. This differences in self-reported psychological functioning was a significant 
predictor that explained most between-study variance. Population was a significant 
predictor, with Veterans exhibiting larger effect sizes than athletes. However, population 
was not a significant predictor when simultaneously entered into the regression equation 
with psychological functioning. Overall, across heterogenous populations, the biggest 
predictor of over overall cognitive functioning post-MTBI is psychological functioning.  
Hypothesis 4: When entered into a meta-regression, time since injury, psychological 
comorbidities, and PVT testing will be significant covariates. Effect sizes are expected to 
decrease over time but increase in the presence of psychological comorbidities and 
increase if PVT are not implemented. Whereas, population and age will not reach 
significance. This hypothesis was partially upheld. Psychological functioning was a 
significant predictor of overall cognitive effect size. As predicted, the average age of the 
study sample was not a significant predictor, and population membership was not a 
significant predictor after controlling for psychological functioning. However, mean time 
since injury and utilization of PVTs were not significant predictors.  
Supplemental Analyses 
 Meta-Regression for Acute-Only Studies. Given the unexpected finding that the 
average time since injury was not a significant predictor over overall neurocognitive 
dysfunction, exploratory analyses examined the predictive ability of the various effect 
moderators in the acute (< 90 days) and post-acute (> 90 days) periods post-MTBI. Table 
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12 displays the results of the meta-regression models when considering studies in the 
acute phase, only.  
 In contrast to the model that include all time points, mean time since injury is a 
significant predictor in the meta-regression model for the acute-period, only (Model 1; 
F(1, 106) = 7.49, p < .01). Based on this model, a medium effect size is observed in the 
first 24 hours after injury (d = .490), which drops to a small effect size (d = .20) 41 days 
post-MTBI.  
 When controlling for average time since injury, neither age (t(99) = 0.92, p > .05) 
nor utilization of PVTs (t(106) = 1.69, p > .05) were significant predictors of overall 
neurocognitive dysfunction in the first 90 days after sustaining an MTBI (Model 2, 
Model 3). Consistent with the previous models, psychological functioning was a 
significant predictor (t(19) = 7.96, p < .001) with nearly all between-study variability 
accounted for by the model (R2 Analog = .99). When entered into the same model with 
psychological functioning, mean time since injury fails to reach significance (Model 4; 
t(19) = 0.42, p > .05)5. In contrast to the previous models, population membership was 
not a significant predictor of overall neurocognitive dysfunction in the acute periods post-
MTBI (F(3, 102) = 1.93, p > .05). This may be due to the absence of studies with Veteran 
populations, which was a significant predictor in the previous models. 
 
5 It is worth noting that CMA 3 eliminates studies in a list-wise fashion. When considering the 20 studies 
that included measures of psychological functioning, mean time since injury, by itself, was not a significant 
predictor. Thus, the lack of significance of time to be a significant predictor is not necessarily an indication 
that psychological functioning accounting for all of the variability, making time since injury non-
significant.  
  88 
 
 
 
 
 
 
Table 12
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction in the First 90 Days Post-MTBI
B SE t B SE t B SE t B SE t B SE t
Intercept 0.49 0.057 8.56*** 0.378 0.128 2.95** 0.365 0.094 3.90*** 0.027 0.091 0.3 0.459 0.067 6.90***
MTSI -0.007 0.003 -2.74** -0.007 0.003 -2.56* -0.007 0.003 -2.59** 0.001 0.003 0.42 -0.007 0.003 -2.61**
Age 0.005 0.005 0.92
PVT 0.164 0.097 1.69
Psych d 0.512 0.064 7.96***
Population
     GMR 0.004 0.093 0.04
     Litigant 0.032 0.157 0.21
     Veteran 0.536 0.225 2.38
k
Model F
Q
I
2
R
2
 Analog
Notes.  MTSI = Mean Time Since Injury; PVT = Performance Validity Testing; GMR = General Medical Referall; Psych d = The effect size of psychological distress 
For PVT, the reference group is studies that utilized PVTs to screen for adequate effort; For Population, the reference group were studies that included Athletes 
* = p  < .05; ** = p < .01; *** = p < .001
Model 5
F(3,102) = 1.93
107 100 107 20 107
Model 1 Model 2 Model 3 Model 4
3.40*
410.2*** 384.16*** 409.63*** 17.72 468.2***
7.49** 3.60* 5.14** 32.30***
77.36%
0.14 0.15 0.13 0.99 0.22
74.40% 74.75% 77.36% 4.05%
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Figure 12 
Scatterplots of Time Since Injury and Acute Overall Cognitive Dysfunction  
 
 
 
 
 
 
 
Note. The size of the circles in the plot represent the relative weight each study has on the 
overall observed effect size 
 
Meta-Regression for Post-Acute Studies. Meta-regression models were 
conducted when considering studies in the post-acute periods after sustaining an MTBI (> 
90 days) and results are described below.  
 Mirroring the results from meta-regression model with all time points considered, 
the models with time since injury (F(1, 44) = 1.02, p > .05), age (F(1, 43) = 1.81, p > 
.05), or the utilization of PVTs (F(1, 44) = .04, p > .05) failed to reached statistical 
significance. Similar to the earlier models, psychological functioning (F(1, 15) = 14.35, p 
< .001) and population (F(3, 41) = 17.01, p < .001) were significant when these variables 
were modeled alone. When both variables were entered into the same equation, 
psychological functioning remained a significant predictor (t(15) = 3.81, p < .01), 
whereas population membership failed to reach significance (F(3, 11) = 0.22, p > .05). 
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Table 13
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction 90 Days or More After MTBI
B SE t B SE t B SE t B SE t B SE t B SE t
Intercept 0.234 0.191 1.22 0.024 0.298 0.08 0.434 0.248 1.75 0.087 0.074 1.17 0.125 0.115 1.09 -0.18 0.471 -0.38
MTSI 0 0 1.01
Age 0.013 1.35 0.185
PVT -0.052 0.276 -0.19
Psych d 0.372 0.098 3.79** 0.401 0.105 3.81**
Population
     GMR 0.137 0.15 0.91 0.266 0.47 0.57
     Litigant 0.311 0.169 1.84 0.272 0.467 0.58
     Veteran 1.733 0.249 6.96*** 0.059 0.549 0.11
k
Model F
Q
I
2
R
2
 Analog
Notes.  MTSI = Mean Time Since Injury; PVT = Performance Validity Testing; GMR = General Medical Referall; Psych d = The effect size of psychological distress 
For PVT, the reference group is studies that utilized PVTs to screen for adequate effort; For Population, the reference group were studies that included Athletes 
* = p  < .05; ** = p < .01; *** = p < .001
Model 6
F(3,11) = 0.22
45 44 45 16 45 16
F(3,41) = 17.10***
Model 1 Model 2 Model 3 Model 4 Model 5
3.75*
335.48*** 334.67*** 335.88*** 19.08 337.43*** 4.06
1.02 1.81 0.04 14.35** 17.10***
0.01%
0.01 0.01 0.01 0.99 0.80 0.99
87.18% 87.45% 86.96% 21.38% 86.96%
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Figure 13 
Scatterplots of Time Since Injury and Post-Acute Overall Cognitive Dysfunction  
 
 
Note. The size of the circles in the plot represent the relative weight each study has on the 
overall observed effect size 
 
 
 
Demographic Variables: Neither the meta-regression model with the mean 
education level as a covariate(F(1,85) = 1.49, p = .225), percentage of females included 
in the study sample (F(1,139) = .13, p = .717),  nor the percent of ethnic minorities 
included in the study sample (F(1,45) = .17, p = .069) were significant predictors of the 
overall cognitive effect size post-MTBI.  
Injury Parameters.  Neither the meta-regression model with the percentage of 
individual who reported LOC as a covariate (F(1,63) = .01, p = .928) nor the percentage 
of individuals who reported PTA (F(1,45) = 1.75, p = .193) reached statistical 
significance.   
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Post-Concussive Symptomology. Seven studies had two independent sub-groups 
comprised of individuals who were identified as having PCS and individuals who did not 
have PCS. A large overall cognitive effect was observed in the sub-groups that included 
individuals with PCS (d = .890 after average of 167.2 days) and a medium-large effect 
was observed in the sub-group of participants who did not report PCS (d = .649 after 
average of 168.4 days). However, the Analogue-to-ANOVA failed to reach significance 
(Q Between(1) = .155, p = .693), suggesting no difference between the two groups.  
In contrast, the effect size of self-reported PCS in the MTBI group relative to the 
control group did significantly predict the overall neurocognitive effect size, with 76% of 
the between-study variability accounted for by the covariate (See Table 14; Model 1). 
However, this variable failed to reach significance once psychological functioning was 
entered into the model simultaneously (Model 2).  
 Study Characteristics: Consistent with previous studies, there was a significant 
difference in the observed effect sizes based on the control groups (Q Between(4) = 
12.469, p = .014). Studies with non-injured control groups (d = .497) yielded an effect 
size that was significantly larger than the effect size from all other control groups. 
Control groups that consisted of individuals with orthopedic injuries yielded the next 
largest effect size (d = .257), though the magnitude of this effect was not significantly 
larger than any of the estimated effect sizes from other control groups. Studies that 
utilized both non-injured controls and pre-injury baselines yielded the next highest effect 
size (d = .216), though this failed to reach significance. The studies utilizing individuals 
who sustained a trauma and individuals with chronic pain as their control group yielded 
small, non-significant effect sizes (d = .038 and -0.063, respectively).  
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Table 14
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction After MTBI
B SE t B SE t
Intercept -0.031 0.047 0.508 0.013 0.07 0.19
PCS d 0.393 0.043 9.03*** -0.013 0.15 -0.08
Psych d 0.521 0.162 3.21**
k
Model F
Q
I
2
R
2
 Analog
Notes.  PCS = Post-Concussive Symptomology; Psych d = the effect size indicating 
overall psychological functioning 
* = p  < .05; ** = p < .01; *** = p < .001
37.62% 1.00%
0.76 0.99
81.47*** 36.28***
113.81*** 10.32
73 22
Model 1 Model 2
Table 15.
Overall Cognitive Dysfunction Post-MTBI Stratified by Control Group
k d 95% CI Q I
2
Non-Injured Control 100 0.497*** .394-.599 499.055*** 80.163
Non-Injury Control & 
Pre-Injury Baseline 14 0.216 -.030-.463 36.788*** 64.663
Orthopedic Injury 30 0.257** .080-.435 132.047*** 78.038
Chronic Pain 3 -0.063 -.601-.475 18.237*** 89.033
Trauma Control 3 0.038 -.517-.592 0.702 0.01
Q Between 12.469*
Notes.  * = p < .05; ** = p < .01; *** = p < .001
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Discussion 
Mild traumatic brain injuries are a significant public health issue with respect to 
pervasiveness (Cassidy et al., 2004) and economic burden (Ma et al., 2014; Max et al., 
1991). While it is well documented that many individuals recover from MTBI in as little 
as nine days (e.g., McCrea, 2008), there are others who take up to 3 months for complete 
neurocognitive recovery (e.g., Belanger, Curtiss, et al., 2005), and still others who fail to 
return to their cognitive baseline years after their injury (Ruff, Camenzuli, & Mueller, 
1996). Emerging research has identified a multitude of factors that might contribute to 
protracted cognitive recovery from MTBI. However, due to differences in study 
methodology, discrepant findings are pervasive in this broad literature, which creates 
challenges for clinical researchers and healthcare professionals in management of MTBI. 
Due to the number of potential factors that are likely to modify cognitive recovery, 
empirical studies controlling for each of these factors would be difficult. Rather, 
quantitative reviews have attempted to elucidate the effects of such variables (e.g., 
Belanger, Curtiss, et al., 2005; Belanger & Vanderploeg, 2005; Dougan et al., 2014). 
These studies have been instrumental in furthering our understanding MTBI recovery 
across different variables of interest. However, these meta-analytic studies examined 
homogenous populations with restricted time frames, somewhat limiting their 
generalizability.  
The present study was an updated quantitative review of the MTBI literature that 
simultaneously utilized traditional and contemporary meta-analytic techniques. This 
study sought to determine how demographic factors (e.g., age), individual differences 
(e.g., psychological functioning), and study designs (e.g., utilization of PVTs) might 
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explain the apparent differences in neurocognitive recovery from MTBI across a 
heterogenous population (e.g., athletes, Veterans, GMR, litigants). Capitalizing on the 
recent explosion of literature, this study is the largest MTBI meta-analytic review to date.  
Aim 1 
The first aim of this study was to utilize traditional meta-analytic techniques to 
determine if differences in observed effect sizes differed across various moderator 
variables of interest. This was done by conducting multiple analyses via Analogue-to-
ANOVA across each time point and effect modifier. Regarding overall neurocognitive 
dysfunction, a medium-large effect size was observed in the initial 24 hours post-MTBI 
that decreased to a small effect size over the first 90 days. Contrary to expectation, 
however, the observed effect size appeared to increase from small to small-medium for 
studies where assessments were conducted 90 days post-injury. This, however, was likely 
driven by the larger proportion of studies with samples consisting of Veterans and 
individuals involved in litigation in this time strata (k = 14 of 45). Effect sizes across 
cognitive domains followed this general pattern with significant effect sizes for every 
domain except orientation and fine motor movement after 90 days post-injury.  
While this finding is surprising, it is not unique within the meta-analytic literature. 
In Belanger, Curtiss, and colleagues’ (2005) meta-analysis, which included a 
heterogenous clinical sample (individuals involved in litigation, prospectively recruited 
patients, and patients selected due to continued symptom report), significant effect sizes 
were observed, even in the post-acute (>90 day) periods across nearly all cognitive 
domains (d range =.15 to .71). After multiple pair-wise analyses were conducted, the 
authors determined that this effect was driven by an increase in observed effect sizes 
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from individuals involved in litigation and patients recruited due to persistent 
symptomology. Similarly, the overall effect sizes in the present study diminish with time 
until the most post-acute time point (> 90 days) when there were a larger number of 
studies that included individuals involved in litigation and Veterans. 
Further moderator analyses in Aim 1 sought to examine differences in the 
observed effect size of overall cognitive functioning across various effect modifiers. 
Consistent with expectation, differences in observed effect sizes were evident across the 
various populations of interest (i.e., athletes, Veterans, GRM, litigants), with studies that 
included Veterans having a significantly larger effect sizes than studies that included 
other populations. This is unsurprising given the exceedingly high rate of psychological 
comorbidities that accompany Veterans post-deployment (Brenner et al., 2010), MTBI 
might not be treated or detected in combat theater in favor of treating other injuries 
(Belanger, Scott, et al., 2005), and the inherent medicolegal nature of obtaining medical 
services for US Veterans.  
Similar to Belanger, Curtiss, and colleagues’ (2005) study, the observed effect 
size for studies with litigant populations increased in the post-acute (> 90 days) periods 
after an MTBI. For reasons not entirely clear, the observed effect sizes in the present 
study for this population in the post-acute period (> 90 days) is meaningfully smaller than 
what was observed in Belanger’s study (d = .437 vs .777). This may due to 
methodological differences in the authors using a fixed-effect analysis, which tends to 
lead to higher effect sizes. More likely, this is due to the author’s decision to include 
studies with complicated MTBI, which were excluded in the present study. Complicated 
MTBI (i.e., evidence of skull fracture or brain hemorrhage), has a prolonged recovery 
  97 
 
course more like moderate TBI than MTBI. The smaller-than-expected effect size for 
litigant samples may explain why the differences in effect size between litigant, GRM, 
and athlete samples only trended towards significance. While the observed effect sizes 
were not statistically smaller than litigant samples, the effect sizes for athlete samples 
failed to reach significance after 8 days, which is consistent with the well-established 
empirical literature (Belanger & Vanderploeg, 2005; Dougan et al., 2014; McCrea, 2008).  
There is an increased recognition of the importance of administering PVTs during 
clinical evaluations to detect suboptimal effort, which may confound results (Chafetz et 
al., 2015). While studies that screened for invalid performance yielded smaller effect 
sizes than studies that did not utilize PVTs, unexpectedly, these differences failed to 
reach statistical significance at any timepoint. However, a similar pattern was found in 
Belanger and Curtis’ (2005) analysis. For studies that involved litigant samples, they 
found that the studies that screened for insufficient effort had a smaller observed effect 
size (d = .50) than studies that did not utilize PVTs (d = .66), though this difference failed 
to reach significance. Most striking is the overwhelming majority of studies (77%) that 
reported no utilization of PVTs to screen for poor effort despite multiple professional 
organizations imploring their utilization in clinical work and research (e.g., Chafetz et al., 
2015). 
It is clear that most of the MTBI research included in these analyses focused on 
adolescents and adults, which is problematic given that that children aged 0-4 years and 
adults aged 75 are particularly prone to head injuries (Faul et al., 2010). Given the 
discrepancy in empirical findings (e.g., Anderson et al., 2001; Grubenhoff et al., 2010; 
Ponsford et al., 1999), it was important to evaluate age as a potential effect modifier , 
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Consistent with our hypotheses, age was not a significant predictor of neurocognitive 
dysfunction post-MTBI. Notably, however, there was a much smaller percentage of 
studies in the present study that included pediatric and geriatric populations. Thus, it is 
difficult to make definitive conclusions regarding the effect of age from the present 
analysis.  
Unexpectedly, studies that excluded individuals with psychological or psychiatric 
comorbidities did not yield higher effect sizes than studies where comorbidities were 
excluded or presumed to exist. This finding is inconsistent with the rapidly emerging 
literature that psychological functioning largely predicts MTBI outcomes (e.g., Combs et 
al., 2015; Nelson et al., 2012; Verfaellie et al., 2014). This unexpected finding may be the 
result of the lack of nuance from this categorical variable and the assumptions associated 
with coding this variable. That is, most of the included studies were coded as “mixed.” 
Studies were conservatively coded as having a mixed composition if any study 
participant was reported to have a mental health disorder. Thus, there is incredible 
variability in this outcome as studies could be coded as “mixed” if 1 to 99% of their study 
participants were reported to have a comorbid mental health disorder. Additionally, 
studies were coded as mixed if the authors did not report specific inclusion/exclusion 
criteria associated psychological comorbidities. Thus, studies could have been incorrectly 
coded if the authors did not formally measure psychological outcomes. Altogether, this 
unexpected finding may be a result of methodological decisions associated with 
developing a categorical coding of this variable, which may not be particularly 
meaningful.  
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Notably, limitations associated with methodological approaches utilized in Aim 1 
are consistent with most prior MTBI meta-analyses conducted. Analogue-to-ANOVA 
analyses require categorical data, restricting the variability of the effect modifiers. This 
type of analysis also requires a separate analysis for each covariate and time point of 
interest. Altogether, 20 separate analyses were needed to examine the impact of the 
various effect modifiers on MTBI recovery over time, likely resulting in Type I errors. 
Additionally, there is an inherent reduction in power as included studies are split among 
the various analyses (largest k = 45). Consistent with nearly every previous MTBI meta-
analysis, significant between-study heterogeneity (Cochran’s Q) was evident after most 
analyses, leaving a significant majority of the variability left unexplained (I2) (Belanger, 
Curtiss, et al., 2005; Belanger & Vanderploeg, 2005; Frencham et al., 2005; Rohling et 
al., 2011).  
Aim 2 
The second aim of this study was to utilize meta-regressive techniques to quantify 
the relative effect in overall neurocognitive functioning post-MTBI for each covariate, 
and more fully account for the between-study heterogeneity evident in the literature and 
replicated in Aim 1. Unlike the pairwise analyses from Aim 1, meta-regression analyses 
can quantify the relative effect of each covariate on neurocognitive recovery with much 
fewer analyses. Furthermore, the covariates can be examined continuously, rather than 
categorically, maintaining important variability.  
 When considering all studies with time of assessment ranging from immediately 
post-injury to three years, average time since injury did not predict overall neurocognitive 
dysfunction. This held true when considering linear and non-linear equations. Again, this 
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surprising finding was likely due to the comparatively large effect sizes for studies that 
included individuals involved in litigation and Veterans. To further explore this issue, 
supplemental analyses revealed that the average time that had elapsed since sustaining an 
MTBI was a significant predictor only when examining the first 90 days after injury. This 
variable, however, failed to be predictive when examining studies in the post-acute (>90 
days) period. Taken together, this seems to suggest that in the post-acute periods after an 
MTBI, when symptoms are not typically present, the amount of time that has passed 
since the injury is no longer important in predicting overall cognitive functioning. Rather, 
other key variables are likely to account for any residual differences between MTBI 
populations and controls.  
Given the consistent findings demonstrating a deleterious effect of psychological 
distress and MTBI recovery (e.g., Combs et al., 2015; Nelson et al., 2012; Verfaellie et 
al., 2014) it was important to evaluate emotional well-being in more systematic and 
objective manner than in Aim 1. Uniquely, this is the first meta-analysis to systematically 
examine psychological functioning after sustaining an MTBI.  Analyses revealed that 
psychological functioning was a significant predictor of neurocognitive dysfunction, 
accounting for nearly 100% of the between-study variability despite only including 36 
studies ranging from 2 to 954 days post-MTBI. While population membership was a 
significant predictor, accounting for 30% of the between-study variability when 
considered alone, this variable failed to reach significance when entered to the regression 
equation simultaneously with psychological functioning.   
The effect of psychological functioning seems to be primarily driven by studies 
including individuals who have depression and/or PTSD (see Table 16). This is generally 
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consistent with emerging MTBI research  (e.g., Combs et al., 2015; Nelson et al., 2012; 
Verfaellie et al., 2014) For example, Nelson and colleagues (2012) found that 3.5 years 
post-injury, Veterans who sustained an MTBI did not differ in overall neurocognitive 
dysfunction compared to controls; whereas, Veterans with MTBI and a comorbid Axis I 
disorder performed much worse than controls, but did perform similar to Veterans with 
no head injury and a comorbid mental health disorder. Similarly, other research has found 
that cognitive and psychological functioning predicted functional outcomes 10 years after 
sustaining an MTBI (Ponsford, Draper, & SchÖNberger, 2008). The importance of 
psychological functioning in predicting cognitive functioning post-MTBI is also 
consistent with research that demonstrates reliable decrements in neuropsychological test 
performance for individuals with mental health disorders in the absence of head injuries. 
For example, it is well-established that depression in older adults is a risk factor for 
cognitive impairment (e.g., Dotson, Resnick, & Zonderman, 2008a). In addition, meta-
analyses have found consistent neurocognitive decrements across the lifespan for 
individuals with depression (Snyder, 2013) and PTSD (Johnsen & Asbjørnsen, 2008). 
What remains unclear is if poor psychological functioning fully explains persistent 
neurocognitive dysfunction in those with protracted recovery, or if continued dysfunction 
may be attributed to the actual head trauma sustained during MTBI (e.g., neurometabolic 
deficiencies, diffuse axonal injuries).  
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While the importance of psychological well-being in predicting cognitive 
functioning post-MTBI is consistent with the existent literature, this finding differs from 
the pair-wise analyses from Aim 1. This difference is likely due to the lack of nuance and 
variability from the categorical variable of the percentage of individuals with 
psychological comorbidities utilized in Aim 1. The variable utilized in Aim 2, however, 
represents overall self-reported psychological functioning and well-being in the MTBI 
group compared to the controls. This continuous variable does not require a diagnosis of 
a mental health disorder to be made as the variable from Aim 1 does. This does, however, 
highlight the importance of psychological assessment as part of routine clinical care for 
MTBI.  
Previous studies with homogenous samples have found that various demographic 
factors, such as sex (Bazarian et al., 2010), education (Dougan et al., 2014), and race 
(Shafi et al., 2007), may modify MTIB recovery.  However, supplemental analyses from 
the present study found that demographic variables (percentage of females and ethnic 
minorities included in the study sample, age, education), injury parameters (percentage of 
participants reporting LOC and PTA), and study characteristics (utilization of PVTs) did 
not predict overall neurocognitive outcomes post-MTBI.  Similar to some published 
Table 16.
Effect Sizes of Various Psychological Constructs 
Construct Depression Anxiety PTSD SUD Somatiziation
Internalizing 
Behavior
Externalizing 
Behavior
Overall 
Psych Fx
k 24 14 6 3 2 12 15 36
d 0.908 0.387 1.926 0.236 0.385 0.230 0.145 0.546
Notes.  PTSD = Post-Traumatic Stress Disorder; SUD = Substance Use Disorder; 
Psych Fx = Psychological Functioning 
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studies (Collie et al., 2006; Iverson et al., 2004; Sterr et al., 2006) supplemental analysis 
did indicate that the report of PCS in the MTBI group relative to the control group did 
predict cognitive functioning. However, much like the other variables, this failed to reach 
significance when simultaneously entered with psychological functioning. Perhaps, the 
initial PCS finding was driven by the affective symptomology of PCS (e.g., irritability, 
fatigue) versus pain (e.g., headache, photophobia), which was better explained by overall 
psychological functioning.  
Overall, the meta-regression models from Aim 2 suggest the time that has elapsed 
after sustaining an MTBI is predictive of neurocognitive dysfunction only in the first 90 
days post-injury. However, psychological functioning is the most important predictor of 
neurocognitive outcomes post-MTBI. That is, across a heterogenous population of 
individuals who sustain MTBI, psychological functioning better predicts neurocognitive 
recovery, over and above the latency from the initial injury.  
Methodological Considerations 
The present study diverged from methodology utilized in prior MTBI meta-
analyses in several meaningful ways. First, a random-effects meta-analysis was 
conducted instead of fixed-effects analysis, which can result in smaller, more 
conservative estimates of effect sizes since two sources of error (within-study and 
between-study) are considered. Additionally, outcomes from multiple time points were 
not averaged as was done in other studies (e.g., Belanger, Curtiss, et al., 2005; Binder et 
al., 1997). Rather, in line with study aims, the time point with the greatest latency since 
the initial injury was selected from each study for analysis. This was done to better 
understand the factors that moderated cognitive recovery as opposed to documenting the 
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more acute effects of MTBI, per se. This decision may have led to systematically smaller 
estimates of effect sizes than if we were to have averaged all the time point comparisons. 
Notably, due to the large number of studies that met potential inclusionary criteria, a 
random sample of articles were reviewed until a specified number (k = 45) of studies per 
population were included. Given that a random-effects analysis assumes a random 
distribution of effects, and the process of reviewing articles was also randomized, we do 
not believe that this process biased the observed effects in any particular direction.  
Finally, in an effort to ensure the construct validity of the cognitive outcomes, this study 
only included validated neuropsychological assessments and excluded experimental 
measures (e.g., fMRI paradigms; Pertab et al., 2009). The ability to be selective with 
psychological assessments is a luxury that previous meta-analyses were not afforded 
given the recent increase in published MTBI research. It is uncertain if this decision 
would lead to a systematic bias in observed effect sizes in either direction. Despite these 
potentially meaningful differences, most of the outcomes were consistent with prior 
analyses. When there were differences, however, the effect sizes tended to be larger; 
though this is most likely due to the increased heterogeneity of study populations relative 
to previous analyses. 
As outlined above, despite these methodological differences, most of the analyses 
from the present study are consistent with the findings from previous meta-analytic 
reviews.  A notable discrepancy in our findings from prior meta-analytics studies was the 
small, but statistically significant effect size that remained in the GMR group after 90 
days, which differed from most meta-analytic studies that divided outcomes by a similar 
time frame (Belanger, Curtiss, et al., 2005; Pertab et al., 2009; Rohling et al., 2011; c.f., 
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Frencham et al., 2005). This finding may be due to the relatively larger inclusion of 
studies in the present analysis (k = 18) compared to previous analyses (mean k = 10.5). 
Notably, most of these previous studies investigated a “mixed” population that included 
some athletes, likely decreasing the observed effect sizes. The only study with a “true” 
GMR sample was Belanger’s (2005a) analysis that included eight studies, which found a 
negligible effect size (d = .04) after 90 days. Perhaps, the small, but significant effect size 
observed in the present study is a more accurate representation of MTBI recovery for this 
group, and this study has the power to detect such finding. Alternatively, this finding may 
be due to a cultural shift in our understanding of the deleterious effects of MTBI in the 
nearly 10 years since the previous GMR study was published, and individuals may be 
more likely to seek medical care when their “bell is rung” rather than “walking it off.”  
While it was consistent with our hypotheses, another divergent finding from 
previous MTBI research was that age was not a significant predictor of post-injury 
cognitive functioning. Dougan and colleagues (2014) found that, in athletes, higher age 
resulted in lower neuropsychological effect sizes. Their study, however, had a relatively 
restricted age range (15-33 years vs. 4.87-69.1 years) and was limited to athletes in the 
acute phases of the injury (1-10 days). The present finding is consistent with a systematic 
review, which found no consistent evidence that age was not a reliable predictor of long-
term neurocognitive functioning. Notably, there was a relative dearth of pediatric and 
older adult studies in the present analysis. This is particularly problematic for 
generalizability as epidemiological studies have found a bimodal distribution in TBI 
prevalence with children and older adults having the highest rate of injury (Faul et al., 
2010).  
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The differences in results from the present study relative to previous meta-
analytic reviews may also be due to the uniqueness of the variables of interest. To our 
knowledge, this is the first published study that included Veteran samples in a 
quantitative review of cognitive functioning after sustaining an MTBI. These analyses 
found that studies that included Veteran populations exhibited significantly larger 
cognitive sequalae after an MTBI relative to their non-injured counterparts. This is likely 
due to the “cumulative model” in which the physical, emotional, cognitive, vocational, 
and psychosocial stressors Veterans face when returning from deployment may 
exacerbate premorbid risk factors, leading to worse outcomes (Evered, Ruff, Baldo, & 
Isomura, 2003; Ruff et al., 1996).  Additionally, the methodological decision to exclude 
studies with assessments greater than three years post-injury resulted in the exclusion of 
many Veteran studies, which preludes a comprehensive understanding of how Veteran 
recovery from MTBI. For example, a preliminary unpublished project stemming from the 
methodology and article selection of the present study found a much smaller effect size 
(Hedges g = .34) across 18 studies when there were no exclusions based on time of 
assessment (mean time since injury = 43.59 months; Marston, 2019). Nonetheless, the 
current project is the first meta-analytic study that attempts to understand the 
neurocognitive trajectory for Veterans and factors that may modify cognitive recovery.  
 Another novelty is the inclusion of psychological variables in this meta-analytic 
study. While many empirical studies (e.g., Combs et al., 2015; Nelson et al., 2012; 
Verfaellie et al., 2014) and systematic reviews (e.g., Carroll et al., 2004) have examined 
the role of psychological functioning in post-MTBI cognitive recovery, this is the first 
meta-analysis, to our knowledge, that attempted to control for the effect of psychological 
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functioning on neurocognitive outcomes. Despite this analysis only including 36 studies, 
the overwhelming ability of psychological functioning to predict study-level data, speaks 
to the importance of emotional well-being for cognitive recovery after an MTBI.   
Despite attempts to systematically integrate a broad literature to derive findings 
that will generalize across populations, the study is not without limitations. One 
limitation of this research is the relatively restricted age ranges of selected samples and 
relatively small number of Veteran samples included, potentially reducing 
generalizability. On the other hand, this study included an extremely heterogenous study 
sample, which has inherent potential for generalizability across many other variables. 
Another limitation is the small number of studies used for the analysis of psychological 
functioning in Aim 2 (k = 36). Given that most studies included did not directly measure 
psychological functioning (>70%) efforts to replace these data (e.g., imputations) were 
not conducted. Nonetheless, the ability of this variable to explain nearly all between-
study variability speaks to its robustness and predictive ability across samples.  
Additionally, a notable criticism of all MTBI meta-analyses is that the methods of 
aggregating outcomes across studies may mask the minority of individuals who 
experience protracted recovery (the so-called “miserable minority”), giving the false 
impression that no one experiences residual cognitive sequalae after three months (Pertab 
et al., 2009). On the contrary, our significant cognitive findings after 90 days suggest that 
these individuals may not be lost in our analyses. Finally, it is important to note that 
meta-regression analyses are inherently observational in nature. The data from the present 
study are study-level data, not patient-level data. Thus, caution needs to be taken in over-
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generalizing these findings and assuming that psychological functioning causes 
protracted cognitive recovery after MTBI. 
Clinical Implications 
Recognizing the significance of psychological functioning status-post injury has 
great clinical utility and should result in improved care and management of individuals 
after an MTBI. Assessment of emotional well-being and psychological functioning 
should be part of routine clinical care for management of MTBI across all populations. 
Individuals who screen high for psychological distress may benefit from a referral for 
brief Cognitive Behavioral Therapy (CBT) or another therapeutic intervention. Brief 
CBT has been found to reduce the duration and severity of PCS after MTBI (Miller & 
Mittenberg, 1998; Silverberg et al., 2013). For example, a small pilot study found that 
individuals who were at high risk for persistent PCS and received brief CBT reported 
fewer symptoms and were less likely to be diagnosed with Post-Concussive Syndrome 
than patients who received treatment as usual (Silverberg et al., 2013). Additionally, this 
study suggests that patients who suffer an MTBI may benefit from psychoeducation 
regarding the overall in the non-specific symptomology between MTBI and mental health 
disorders (e.g., fatigue, inability to concentrate, irritability).  
Patients should be empowered to seek mental health treatment in the acute 
recovery process, especially if there are pre-morbid psychological concerns, rather than 
waiting three months or more. Neuropsychologists, who are uniquely trained to assess 
cognitive, biological, and psychological factors, should be a part of all multi-disciplinary 
MTBI teams. The present research also speaks to the growing need for acute MTBI 
detection and care for military Veterans. Given the high rate of PTSD symptomology 
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(Carlson et al., 2009) and other mental health disorders, our research suggests this 
population is particularly vulnerable to poorer neurocognitive functioning after MTBI. In 
recent years, emphasis on Veteran care and research has increased. For example, the 
Defense and Veterans Brain Injury Center published clinical guidelines for the 
management and clinical care of Veterans with MTBI in 2006 (Moy, Martin, Scwhab, & 
Malik, 2018). Within 30 days of returning from deployment, Veterans meet with a health 
care provider to assess current health functioning and evaluate for deployment-related 
occupational and environmental exposure (Brenner, Vanderploeg, & Terrio, 2009). In 
2008, head injuries were added to the list of environmental exposures that Veterans were 
to be screened. Positive exposure would result in referrals to appropriate services (e.g., 
Poly-Trauma, neuropsychology). Nonetheless, careful and effective screening for mental 
health disorders and expansion of therapeutic services may be beneficial for improving 
Veteran’s long-term functioning after MTBI.   
Summary 
In sum, this study is the largest MTBI meta-analysis to date, which utilized 
contemporary analytic techniques to assess changes in cognitive functioning status-post 
MTBI. A medium-large decrement was observed in overall neurocognitive functioning in 
the very acute (< 24 hours) period post-MTBI. Meta-regression showed time to be 
significant predictor of cognitive functioning in the first 90 days, predicting a small (d = 
.20) effect size after 41 days. After, 90 days, time since injury was no longer a significant 
predictor of cognitive functioning. Psychological functioning was found to be the most 
robust predictor of overall cognitive functioning after MTBI across heterogenous 
samples. Future research should further elucidate and attempt to validate the specific 
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psychological constructs that may confound cognitive recovery. Finally, given the high 
prevalence of MTBI and the general lack of access to healthcare in the US, especially 
with minority groups, CBT or Prolonged Exposure, to treat MTBI via computer or 
telemedicine should be developed.  
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Appendix A 
Flowsheet Outlining Approach to Initial Abstract Review and Article Coding 
 
  
Available 
Information
•Are the titles and abstracts complete? If not, Code 0 - Insufficient Information
•Is it published in English? If not, code "Not Published in English"
Humans
•Does it involve humans?
•No? Code as "Animal Study"
Empiricle 
Study?
•Is this an empirical study? If not, code as "not an empirical study" 
•E.g., poster abstracts, non-systematic reviews, book chapters without data, position statements
•If the article is a systematic review or meta-analysis, code as "Systematic Review/Meta-analysis"
MTBI
• Is the article about the cognitive/psychological effects of sustaining an MTBI? If not, code as "MTBI not primary focus)
• E.g., Adherence to return-to-play protocols, survey of MTBI knowledge among coaches, computer models of hit-velocity ot sustain an MTBI
• Did an MTBI occur?  If not, code "MTBI did not occur"
• E.g., only baseline data; moderate or severe TBI only; healthy controls surveyed for PCS
• Is MTBI poorly defined or lumped together as a "closed head injury" or other antiquated terms that does not delinate injury severity? Code "MTBI not 
Defined"
• Use this one sparingly and infrequently as this may be elucidated  when  coding the full article
Study Design
•Exclude and code if a study is a "csae study/case series" as sample size is too small and would not be approrpiate 
control group
•If no control group is mentioned (self or other) and the results only describe comparison of the MTBI group to 
itself or morderate or severe TBI code "Lack of Appropriate Control Group"
Assessment
•Were neuropsychological or cognitive (not a neurologic exam or GCS) assessed (experimental and tasks used 
during imaging studies are included)? If not, code "No Neuropsychological Assessments Used"
•If all the above criteria is met, however, the study is a behavioral or pharmacological intervention study, code as 
"Intervention study" 
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MTBI Data Entry Code Sheet 
Identifying Information: 
Author – Type in the last name of the first author. 
Year – The year the article was first published. If article was published in print first, then 
online (i.e., re-print), enter the year that the article first appeared in print.  
***Note: If there are multiple articles included in the study with the same first author 
published the same year, differentiate the articles by placing letters (in alphabetical order) 
after the year. Example: Belanger 2005a; Belanger 2005b; Belanger 2005c 
Country – The country that data collection took place. If it took place in multiple 
countries, enter the country that the first author is from.  
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Method Used – Briefly described how MTBI was defined (e.g., “Blunt head trauma; 
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MRI, CT, MEG) or EEG, enter “Yes.” If no neuroimaging is reported as part of the 
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PVTs Used to Exclude Invalid Performance – Enter either “Yes” or “No.” If the study 
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Types of PVTs Used: If “Yes” to “PVTs Used to Exclude Invalid Performance,” then 
enter the types of PVTs used. Enter either, “Stand-alone” (e.g., VSVT, TOMM, WMT), 
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and stand-alone), or “Unspecified” if the article did not directly state how they assessed 
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Control Group: Enter the appropriate control group used in the study. Either “Non-
Injured Controls,” “Pre-Injury Baseline,” “Non-Injured Controls & Pre-Injury Baseline,” 
or “Orthopedic Injury.”  
MTBI Sample Demographics:  
Population -  Enter either: Athlete, Veteran, General Medical Referral, Litigant, or 
Mixed: General Medical/Litigant.  
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Mean Age – Enter the mean age of the MTBI sample 
Age Category – Based on the mean age of the MTBI sample, select: Children (Ages 0-
13), High School/College (Ages 14-22), Adults (Ages 23-64), Older Adults (Ages 65+) 
Mean Education – Enter mean educational attainment of the MTBI sample 
Based on the MTBI sample, enter the percentage of females, percentage of Caucasians, 
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Boxing, Hockey, Rugby, MMA), Other Sport (e.g., Soccer, Basketball, Baseball, 
Wrestling), Motor Vehicle Accident (MVA), Falls, Blast Injury, Veteran Blunt Trauma 
(Veterans who suffered an MTBI due to blunt force trauma – but not due to a blast), 
Civilian Assault (i.e., victims of a crime/mugging), Other Mechanisms (i.e., any other 
mechanism of injury not covered above) 
Complicated TBI – the percentage of individuals who suffered a complicated MTBI 
(i.e., skull fracture, subdural hematoma) as confirmed by neuroimaging 
Psychological Comorbidity & Personality Constructs: 
Composition of Psych Comorbidity – the study specifically states that subjects were 
excluded due to a psychological comorbidity (e.g., depression, PTSD, anxiety), then 
select “0%.” If the sample or subsample of individuals have a diagnosed psychological 
comorbidity, then select “100%.” If the article does not specify, or some individuals (but 
not all) have a mental health disorder, then select “Mixed.”  
 Based on the MTBI sample, enter the percentage of the MTBI sample with a diagnosis 
of Depression, Anxiety, PTSD, and Substance Use Disorder (SUD).  
Time and Time Points: 
Mean Time Since Injury -  Enter the mean time since MTBI occurred (in months) from 
the MTBI sample. If multiple measurements occurred during the course of the study, 
average the time points together. Example: if measurements an evaluation took place at 1 
month and 6 months, then enter “3.5 months.”  
***Note: if the evaluation took place days (rather than months) after the initial 
evaluation, then convert the number of days into months by dividing by 30. If the 
evaluation took place hours after the evaluation, first convert the number of hours post-
TBI into days, then into months by dividing by 30.  
Example:  
7 days = .233 months (7/30) 
 6 hours = .0083 Months (6 / 24 / 30) 
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Time Category: Based on the Mean Time Since Injury, enter the following: < 24 hours, 
< 7days, < 3 months, > 3 months 
Number Post-Injury Time Points: Enter the number of evaluations that took place over 
the course of the study.  
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